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Abstract 
Tuulikki Vehko, Examining time trends in medical practices using register-based 
data – A study on changing coronary heart disease care among persons with 
diabetes. National Institute for Health and Welfare. Research 131. 103 pages. 
Helsinki, Finland 2014. 
ISBN 978-952-302-237-9 (printed); ISBN 978-952-302-238-6 (online publication) 
 
Medical practices are not invariable over time but change concurrently with changes 
in technology: for many clinical problems, new diagnostic and treatment options are 
available. In addition to the adoption of new health care technology, other factors 
associated with changes in medical practice are legislation, resources, policy 
programmes, and clinical guidelines.   
 
The study examined changes in medical practices in coronary heart disease (CHD) 
treatment among persons with diabetes. From the mid-1990s, Finnish CHD 
treatment practice trends in medication and coronary revascularisations were 
examined at the level of the entire health care system and between different patient 
groups.  
 
The study used individual-level register-based data and compared yearly cohorts of 
the Finnish population with diabetes and/or CHD. Data concerning filled 
prescriptions of anti-hypertensive medication and lipid-lowering medication were 
gathered from the health insurance register. Coronary revascularisations were 
identified in the Finnish Hospital Discharge Register. Of the four longitudinal sub-
studies, two examined the use of medication to prevent CHD complications, one 
study examined access to coronary revascularisation, and one study focused on 
persons with a history of coronary revascularisation and examined their treatment 
pathways. Risk-adjustment methods were used to control confounding factors and 
thereby to ensure comparability between patient groups and socioeconomic groups.  
 
Use of medication to prevent CHD and its complications increased in all patient 
groups. Among patients with newly diagnosed CHD, beta blocker use was found to 
be generally equitable throughout the study period. Newer renin-angiotensin-
aldosterone system inhibitors were more commonly used by patients with diabetes. 
Among patients with CHD, socioeconomic differences were found in lipid-lowering 
medication use before 2000, but the differences disappeared after a health insurance 
reform in which reimbursement of drug costs for lipid-lowering medication among 
CHD patients increased from the basic reimbursement (50%) to a higher category 
(75%). In 2000–2006, the use of lipid-lowering medication among newly diagnosed 
diabetes patients differed in the lowest income quintile from other income groups, 
remaining about 10 percentage units lower compared to the overall level.  
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During the study period, the use of PCI (percutaneous coronary intervention) 
increased substantially and CABG (coronary artery bypass graft) decreased in 1995–
2002 in Finland. However, CABG remained the more common of the two 
procedures among patients with diabetes and CHD. Despite the increase of coronary 
revascularisations, a socioeconomic gradient was found in access to the operation 
throughout the study period. During the study period (1998–2007), medical practices 
in performing coronary revascularisation changed to performing the operation at the 
first hospital admission. Among patients with diabetes, pathways to coronary 
revascularisation included more emergency admissions compared to patients with 
CHD only.  
 
The results of this study on changes in CHD treatment over time among patients 
with diabetes and/or CHD indicate that, in general, recommended treatment 
practices have become more common. Knowledge of how trends and factors 
associated with medical practice change over time adds to our understanding of 
medical practices and their development. The non-experimental methods used in the 
study to investigate changes in medical practice over time in different patient groups 
proved to be suitable for describing the level and distribution of treatment overall 
and in different patient groups. 
 
Keywords: register-based study; medical practices; longitudinal study; diabetes; 
coronary heart disease  
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Tiivistelmä 
Tuulikki Vehko, Hoitokäytäntöjen ajallisten muutosten tutkiminen 
rekisteriaineistossa – Tutkimus muuttuvista sepelvaltimotaudin hoitokäytännöistä 
diabeetikoilla. Terveyden ja hyvinvoinnin laitos. Tutkimus 131. 103 sivua. Helsinki, 
Finland 2014. 
ISBN 978-952-302-237-9 (painettu); ISBN 978-952-302-238-6 (verkkojulkaisu) 
 
Lääketieteelliset hoitokäytännöt eivät ole pysyviä, vaan ne muuttuvat osana 
teknologista kehitystä, jonka ansiosta moniin oireisiin ja tauteihin on tarjolla uusia 
diagnoosi- ja hoitomenetelmiä. Terveydenhuollon uusien teknologioiden lisäksi 
myös muut tekijät kuten lainsäädäntö, käytettävissä olevat voimavarat, kansan-
terveysohjelmat ja hoitosuositukset vaikuttavat lääketieteellisten hoitokäytäntöjen 
muutokseen. 
 
Tämän tutkimuksen tarkoituksena on kuvata lääketieteellisten hoitokäytäntöjen 
muutosta sepelvaltimotaudin hoidossa yleensä ja erityisesti niiden potilaiden 
keskuudessa, joilla on myös diabetes. Tutkimuksessa kuvataan sepelvaltimotaudin 
sekä lääkkeellisen että invasiivisen hoidon kehitystä 1990-luvun puolestavälistä 
alkaen koko terveydenhuollon tasolla ja potilasryhmittäin.   
 
Tutkimuksessa käytetään yksilötasoisia rekisteriaineistoja ja verrataan 
vuosikohorteittain suomalaisia diabeetikoita, joilla on tai ei ole sepelvaltimotautia. 
Tiedot ostetuista verenpainelääkkeistä ja veren rasva-arvoja alentavasta lääkityksestä 
on saatu reseptilääkkeiden korvausrekisteristä ja tiedot sepelvaltimoiden 
pallolaajennuksista ja ohitusleikkauksista hoitoilmoitusrekisteristä. Osatutkimusten 
tutkimusasetelmat hyödyntävät rekisteritutkimuksen mahdollisuuksia pitkittäis-
tutkimukseen: kaksi osatutkimusta tarkastelee sepelvaltimotautilääkitystä, yhdessä 
tutkimuksessa tarkastellaan sepelvaltimotaudin invasiiviseen hoitoon pääsyä, ja 
yhdessä tutkimuksessa tarkastellaan toimenpidettä edeltäviä hoitopolkuja niiltä, 
joille oli tehty sepelvaltimoiden pallolaajennus tai ohitusleikkaus. Eri ryhmien 
välisten vertailujen luotettavuuden lisäämiseksi mallinnuksessa käytetään 
rekisteriaineistoihin sopivia vakiointimenetelmiä.    
 
Sepelvaltimotaudin hoidossa käytettävä lääkitys lisääntyi tarkasteluajanjaksolla 
kaikissa potilasryhmissä. Sepelvaltimotautipotilailla ei ollut tutkimusajanjaksolla 
sosioekonomisia eroja beettasalpaajien, eikä angiotensiinikonvertaasientsyymin 
estäjien (ACE:n estäjien) tai angiotensiinireseptorin salpaajien käytössä. Uudemmat 
ACE:n estäjät ja angiotensiinireseptorin salpaajat olivat sepelvaltimotautia ja 
diabetesta sairastavilla yleisemmin käytössä kuin niillä, joilla oli ainoastaan 
sepelvaltimotauti. Sosioekonomisia eroja veren rasva-arvoja alentavassa 
lääkityksessä havaittiin sepelvaltimotautipotilailla ennen vuotta 2000, mutta erot 
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katosivat samana vuonna toteutetun lääkekorvausjärjestelmän muutoksen jälkeen. 
Tuolloin veren rasva-arvoja alentavan lääkityksen, käytännössä statiinien, 
erityiskorvausoikeus (75 %) laajennettiin koskemaan myös sepelvaltimo-
tautipotilaita. Statiinien käyttö uusien diabetespotilaiden keskuudessa erosi alimman 
sosioekonomisen ryhmän osalta vuosina 2000–2006: käyttö oli noin 10 
prosenttiyksikköä muita matalammalla tasolla.  
 
Sepelvaltimoiden pallolaajennusten määrä lisääntyi Suomessa huomattavasti ja 
ohitusleikkausten määrä väheni 1995–2002, diabeetikoiden keskuudessa ohitus-
leikkaukset kuitenkin säilyivät yleisemmin käytettynä hoitomuotona. Vaikka 
toimenpiteiden yhteislukumäärä lisääntyi huomattavasti, oli sepelvaltimotaudin 
invasiivisiissa hoitotoimenpiteissä portaittaisia sosioekonomisia eroja: mitä ylempi 
tuloryhmä sitä suurempi leikkaustodennäköisyys. Sydäntoimenpiteen läpikäyneistä 
potilaista diabeetikoilla oli muita enemmän ????????????????? toimenpiteeseen  
???????????hoitopolulla.  
 
Tutkimusajanjaksolla sepelvaltimotaudin hoitokäytännöt muuttuivat ja suositusten 
mukaiset hoitokäytännöt lisääntyivät. Tieto hoitokäytäntöjen kehityssuunnista ja 
hoitokäytäntöjen muutokseen liittyvistä tekijöistä voi auttaa kehittämään käytäntöjä. 
Tutkimuksessa käytetty epäkokeellinen, todellisia potilasaineistoja hyödyntävä 
rekisteripohjainen tutkimusmenetelmä osoittautui käyttökelpoiseksi, kun tarkas-
teltiin hoitokäytäntöjen muutosta ja hoitotoimenpiteiden jakautumista eri ryhmissä.     
 
Avainsanat: rekisteritutkimus; hoitokäytännöt; pitkittäistutkimus; diabetes; sepel-
valtimotauti  
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1 Introduction 
The present study focused on changes in medical practice over time in medication 
use and surgical operations to prevent and treat coronary complications among 
persons with diabetes. The question is important for several reasons. An important 
issue is the technological change that has taken place in the treatment and prevention 
of coronary heart disease CHD. Secondly, both diabetes and  CHD are common chronic 
diseases, but earlier studies of medication use and surgical operations have mainly  
concerned hospitalised MI patients, and results concerning unselected patient populations 
have been scarce. Thirdly, some studies from other countries have reported that CHD 
treatment for patients with diabetes has not been as intensive as for those without 
diabetes, even though the treatment guidelines underline the importance of active 
prevention and treatment of CHD complications among patients with diabetes. 
Fourthly, this study was undertaken to detect potential undertreatment of certain 
patient groups by examining medication use and coronary revascularisations by 
socioeconomic position. Fifthly, an initiative to focus on prevention of diabetes as 
well as to prevent CHD and its complications among patients with diabetes 
(DEHKO) was launched to address the increasing burden on health care system 
during the study years. For these reasons the medical practices were extracted from 
administrative registers, and using individual-level information, the sub-studies 
explore changes in medical practice over time. The changes over time are discussed 
in the context of concurrent interventions in health insurance and treatment 
recommendations as well as changes in resources. 
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2 Background of the study 
2.1 Conceptual background 
 
 
Figure 1. The conceptual background of the study   
The present study first describes the key concept of the study, medical practices, and 
the shift of focus in earlier literature from regional variations to changes in medical 
practice over time. Secondly, factors affecting changes in medical practices are 
introduced. Thirdly, a landscape of empirical research on changes in medical 
practice over time using register-based data is presented. Fourthly, factors affecting 
medical practices in CHD treatment are described from the mid-1990s onwards in 
Finland with a special interest in patients with diabetes. Finally, using Finnish 
register-based data, changes in the treatment of CHD are examined in terms of 
medication and coronary revascularisation. The sub-studies describe changes in 
medical practice over time in an unselected patient population, focusing on persons 
with diabetes. 
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2.1.1 Changing medical practices  
 
Medical practices are considered to include those activities in the care process where 
the physician and the patient meet: diagnosis, prescriptions, surgical and other 
treatment, hospital admissions and discharge. Medical practice is often also 
considered to be based on scientific evidence (Andersen & Mooney, 1990) and to be 
produced in a continual process of interaction between medical practice and medical 
science. Nevertheless, there is a lack of evidence on some interventions, and 
moreover, despite the available evidence, the actual practices may differ from those 
recommended. (Andersen & Mooney, 1990; Farlex, 2012) The present evidence 
comes from studies that reported variations in medical practices even after taking 
into account clinical variables and patient characteristics (McPherson et al., 1982; 
Andersen & Mooney, 1990). Whereas the main focus in studies concerning medical 
practice variation has been on geographical variations, i.e. regional differences in 
health service production, medical practice variations have also been examined 
across time periods (Westert et al., 2004; Fonarow et al., 2007; Chin et al., 2011). 
 
An early study of regional variation in health services was published by Glover in 
the UK in the late 1930s. The study reported variations in the rate of tonsillectomy 
procedures between regions, and it has inspired replications later. (Glover 1938; 
McPherson 2008) Medical practice variation has been documented in the USA since 
the 1970s by pioneers such as Wennberg and Gittelsohn. They described differences 
in common surgical procedures and, for instance, reported large variations in the 
history of hysterectomy among women under the age of 75. The percentage of 
women who had undergone a hysterectomy varied from 25% to 70% between 
towns. (Wennberg & Gittelsohn, 1973)  Since these classic pioneer studies, a large 
body of literature has examined small area variations in medical treatments in the 
industrialised countries (Keskimäki et al., 1994; Black et al., 1995; Birkmeyer et al., 
1998; Dunn et al., 2005; Lysdahl & Borretzen, 2007; Bhatnagar et al., 2010; 
Maheshwari et al., 2011; Pearce-Smith, 2011; Welch et al., 2011). 
 
Examining medical practice variations between health care providers requires large-
scale administrative databases. Collecting information on health care utilisation into 
electronic databases has provided opportunities to calculate population-based rates 
in many countries since the 1970s. After taking clinical variables and patient 
characteristics into account using relevant statistical methods, the studies reported 
variation in the measured rates of surgical procedures and also pharmacological 
treatments. For instance, international comparisons of common surgical procedures 
between the USA, the UK, Canada and the Nordic countries showed remarkable 
variation between countries. However, variations within countries have been 
reported to be as large as those between countries. (McPherson et al., 1982; 
Background of the study 
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Andersen & Mooney, 1990; NOMESCO, 2011) The topic has attracted widespread 
interest. At the international level, the Organization for Economic Cooperation and 
Development (OECD) and the Nordic Medico-statistical Committee (NOMESCO) 
in the Nordic countries regularly gather and publish information on variations in 
health care between member states (OECD, 2011; OECD, 2012). At the national 
level, many countries such as the USA, Australia, the UK, the Netherlands, Sweden 
and Norway regularly monitor medical practice variation within the country (Page et 
al., 2007; NHS,2011a; NOMESCO,2011; Westert et al., 2011; The Dartmouth Atlas 
Project Group, 2013).  
 
Variation in medical practices can be both warranted and unwarranted. Unwarranted 
variation is “variation in the utilisation of health care services that cannot be 
explained by variation in patient illness or patient preferences” (Wennberg, 2002). 
Two main sources of unwarranted variation have been identified, namely health 
service resources available (e.g. health care professionals and their skills, 
techniques, medical devices, availability of operating theatres, waiting lists and 
regulation of supply) and practice patterns among physicians, i.e. appropriateness of 
intervention or referral practices (de Jong, 2008; O'Donnell 2000). Both health 
service resources and practice patterns have been reported to have an effect on 
clinical decision making (McPherson, 1990). From the perspective of patients, 
sometimes an opportunity to request a second opinion from a different physician is 
needed (van Dalen et al., 2001; Moumjid et al., 2007). Warranted variation is 
preference-sensitive instead of supply-sensitive and echoes informed and shared 
decision making between the patient and health care professionals (Appleby et al., 
2011; Mercuri & Gafni, 2011).  
 
There are areas in the practice of medicine where evidence of best treatment is weak. 
Uncertainties of patient care and clinical decisions that doctors face sometimes 
overshadow the inherent uncertainty of the medical profession. (de Jong, 2008; 
McPherson, 2008) Uncertainty can concern the best option for effective treatment in 
terms of prognosis or in terms of quality of life. An example of this is in the 
treatment choices between surgical and radiation therapy for prostate cancer (Fowler 
et al., 1988; Barry et al., 1995; Kirschner-Hermanns & Jakse, 2002). 
 
At the population level, unwarranted variation in treatment practices could be 
examined after adjusting for  different comorbidities by studying variation between 
sub-populations (between men and women, between age groups, between income 
groups). An approach of this type documents potential inequalities in health care 
utilisation. Earlier mainly cross-sectional research has reported both positive and 
negative associations between patients’ socioeconomic position and rates of surgical 
procedures (Keskimäki et al., 1994; Skinner et al., 2003; Westert et al., 2003; Blum 
& Ibrahim, 2012) and medication treatments (Fialova et al., 2005; Gaskin et al., 
Background of the study 
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2006; Rothberg et al., 2008; Sargen et al., 2012; Rowlingson et al., 2013; Aarnio et 
al., 2014). 
 
Examining medical practice variations in health service utilisation provides a 
strategy for non-experimental assessment of health care (Andersen & Mooney, 
1990). Practice variation may be studied at different levels, from considering the 
individual physician or patient as a decision maker to the level of an entire health 
care system. Data requirements change depending on the focus of the research: 
studies on variation between physicians (micro level) use qualitative methods or 
surveys, while studies on variation between health care organisations (hospitals, 
practices) (meso level) and medical practice variations between countries (macro 
level) use administrative databases. Repeated study of databases opens opportunities 
to examine changes in medical practices over time.  
 
The theory of diffusion of innovation can be used as an alternative framework to 
monitor treatment methods used in health care. In the theory, the focus has been on 
individuals as adopters on the one hand and as the locus of decision on the other. 
Moreover, at the organisational level focus has been on communication channels, on 
management of treatment or on profession and population opinions. While 
individuals can be seen as change agents for adoption of the innovation in this 
theory, public health programmes can also be seen as one of the external change 
agencies. Contextual factors affecting diffusion also include structural factors such 
as resources available and regulation. A dissemination curve starts with initial 
introduction and ends at a point of saturation where no further diffusion occurs in 
the absence of changes in other factors. Typically, many factors are in place at the 
time of change, and when monitoring diffusion, causation cannot be attributed to 
any one component conclusively. (McClellan & Kessler, 2002; Berwick, 2003; 
Dearing, 2008)  
 
2.1.2 Factors affecting changes in medical practices  
 
Many factors contribute to changes in medical practices over time at the level of 
society at large and at the level of the health care system. These factors are part of 
changes in the general operational environment of health care, such as technological 
and societal changes. In this chapter, the key factors associated with changes in 
medical practices are discussed on three levels: the macro level referring to the 
policy level, the meso level referring to the health care and community level, and the 
micro level referring to the individual patient or physician level. (WHO, 2002) 
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The health care system where medical practices take place comprises complicated 
systems of networks, but reducing the description to three levels (macro, meso, and 
micro) makes it easier to present the picture systematically, while understanding that 
each of the levels interacts with and influences the others. For each level, common 
challenges have been identified. At the macro level, a lack of coordination in policy-
working may increase the likelihood for waste and fragmentation of health services. 
Lack of standards for health care and intersectoral care of chronic conditions, are 
examples mentioned. Meso-level challenges include lack of continuity of treatment 
for chronic conditions, lack of continuing education for health care professionals, 
practices being not informed (or followed) by evidence, lack of disease prevention, 
and non-functional information systems. Micro-level concerns are connected with 
clinical decision making, the patient-doctor relationship, the empowerment of 
patients and improving health care workers’ communication skills. (WHO, 2002) 
For research purposes, the data needed differ at each of these levels. Register data 
cannot usually provide information on micro-level factors; therefore, despite their 
importance, these are beyond the scope of this register-based study.  
 
2.1.2.1 Legislation and resources  
 
Overall, national governance coordinates population health and health care through 
a variety of mechanisms: enforcing laws and rules, collecting taxes, coordinating 
action, achieving policy coherence and ensuring democratic decision-making 
procedures and accountability (Frenk & Moon, 2013). The right to health care 
services is expressed in legislation and national government responsibilities 
including the directing of health care systems (Wennberg & Peters, 2004). In the 
governance of health care, the main tool is legislation supported by financial 
instruments. There are many players in the field of health care (e.g. professional 
organisations, patient organisations, unions, insurers, enterprises), and therefore 
national governments cannot take their influence for granted. (Jakubowski & 
Saltman, 2013)  
 
Legislation affects the quality of health care by setting standards for health care 
professionals and health technologies. Firstly, licencing medical doctors, nurses, 
physiotherapists and pharmacists guarantees quality in health care through 
legislation (Finlex, 1994; Grol, 2001). Secondly, legislation seeks to ensure the 
safety of technologies (e.g. drugs, medical devices) used in health care (EMA, 
2013).  
 
The influence of legislation goes far beyond the activities that are the most visible to 
health care professionals and citizens, such as health service funding. National 
governance can steer by allocation of resources as well as by controlling 
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expenditure. Both central and local government make decisions on policy 
preferences, where the health care sector competes with other sectors of society for 
resources. Furthermore, within health care various sectors such as primary care and 
specialist hospital care compete for resources. (Sintonen & Pekurinen, 2006) 
 
Many opportunities for controlling medical costs have been recognised at the 
national level and at the EU level. National authorities have used positive lists of 
reimbursed medicines, which are likely for instance to improve prescriptions among 
physicians and moreover to place an obligation on pharmacists for generic 
substitution. (Keskimäki & Vuorenkoski, 2003; Pekurinen & Häkkinen, 2004; 
Häkkinen, 2008; Carone et al., 2012) The use of positive lists of reimbursed medical 
costs for certain diseases has been evaluated by Cochrane collaboration, and the 
review suggests that when incentives are directed to the patient they are more likely 
to facilitate adequate drug treatment than hinder it (Austvoll-Dahlgren et al., 2008).   
 
2.1.2.2 Health technology  
 
Health technology is defined as “any intervention that may be used to promote 
health, to prevent, diagnose or treat disease or for rehabilitation or long-term care” 
and forms a part of innovations used in health care. Health technologies include 
pharmaceuticals, devices, procedures and organisational systems used in health care. 
(WHO, 2011; INAHTA, 2013)  
 
Technological change in surgical procedures offers more accessible surgery to a 
wider population of patients; moreover, these new methods, including mini-invasive 
techniques, are increasingly used in day surgery whereas older techniques have 
usually demanded in-patient treatment. PTCA was introduced in Switzerland in 
1977, and one of its first applications was in the treatment of CHD in the USA 
(Pyörälä & Olkinuora, 1986; Head et al. 2013).   
 
Adopting new health technologies in health care increases the range of medical 
alternatives (de Jong, 2008). A new technology can replace an older technology or 
substitute it. Treatments for certain conditions involve trade-offs between primary 
and secondary care and in cases where a pharmaceutical treatment and a surgical 
procedure are acceptable therapeutic alternatives. While innovations are global, the 
use of health technology takes place locally at a certain point in time, challenging 
the means of delivering health care services. (McClellan & Kessler, 2002)  
 
The management of chronic disease treatment is challenging. These challenges 
become apparent in the case of CHD treatment: on the one hand, there is a need for 
immediate action at the time of a heart attack, and on the other there is a need for 
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persistent long-term treatment in the prevention of complications of CHD. The logic 
and demands of long-term treatment and single episodic provision of treatment 
differ. (WHO, 2002; Nolte et al., 2006; Nolte & McKee, 2008)  
 
Technological change in health care over time has been empirically described in 
treatment of myocardial infarction (MI). Differences between industrialised 
countries in the medical practices of MI treatment were described in the 1990s and 
2000s (Yusuf et al., 1998; Hasdai et al., 2002; Mandelzweig et al., 2006). Recently, 
new drugs such as statins and invasive reperfusion techniques for coronary 
revascularisation have been adopted in the care of MI. Patterns of technology 
adoption between industrialised countries in treatment of MI have been studied 
(McClellan & Kessler, 2002). Comparison of invasive procedures proposes that they 
were more common in the USA than in the UK and Finland in the 1990s, suggesting 
that the economic capability of a country measured by GDP (gross domestic product) 
has a positive impact on the adoption of new and expensive technologies. 
(McClellan & Kessler, 2002; Bech et al., 2009) Concurrently with technological 
changes in MI treatment, a clear descending trend in MI mortality has been reported. 
The reasons behind the MI mortality decline are the subject of ongoing debate, and 
arguments of relative importance of medical technology versus risk reduction 
through lifestyle changes have been presented (Laatikainen et al., 2005; Ford et al., 
2007; Ford & Capewell, 2011). 
 
2.1.2.3 Public health programmes 
 
Policy measures related to health and health care include national strategies, action 
plans, frameworks or development programmes focusing on specific diseases. The 
unifying principle of these policy measures is that they operate on a top-down basis. 
In industrialised countries, government stakeholders conduct these national actions. 
(Ministry of Health and Care Services in Norway, 2007; NHS, 2011b; 
Commonwealth of Australia, 2013; Public Health Agency of Canada, 2013). 
Besides national authorities, international organisations such as the WHO and the 
International Diabetes Federation provide frameworks to improve health. These 
plans vary in their content and scope; some of them have a particular focus on 
primary prevention and others on tackling secondary complications (WHO, 2002; 
Jacob & Serrano-Gil, 2010). The justifications of these plans include reasons related 
to the marked health impact of the disease, such as high prevalence and increasing 
incidence of the disease, high numbers of undiagnosed cases in the population and 
high costs of treatment, or large variation in the treatment of the disease and need for 
reducing area variation or socioeconomic inequities in health. (Ministry of Health 
and Care Services in Norway, 2007; NHS, 2011b; Commonwealth of Australia, 
2013; Public Health Agency of Canada, 2013) 
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Finland has a long tradition of supporting public health programmes, and policy 
tends to be based on an approach that combines prevention, community involvement, 
multi-sectorial collaboration and a high risk strategy in health care. The strategies 
for attaining the objectives have varied from mass media campaigns to management 
of treatment practices in health care. There have been national projects focusing on 
diabetes prevention and care and on asthma, allergy, and mental health care. 
(Haahtela et al., 2006; Saaristo et al., 2007; Haahtela et al., 2008; Mieli, 2009; Aarne 
et al., 2011; Aarne et al., 2011; Kauppi et al. 2013)  
 
Diabetes programmes with national policies and practices to address and respond to 
disease have been implemented in many industrialised countries. The growing 
number of people at a high risk of developing diabetes challenges health care 
services in Europe. In the health care strategy, targets have been set to reduce the 
risk of diabetes, to enhance early diagnosis of diabetes and to facilitate the adoption 
of evidence-based research findings in health care practices. In the Nordic countries, 
Sweden, Norway and Denmark have national plans for diabetes and additionally 
national registers to monitor treatment. (Jacob & Serrano-Gil, 2010; Foundation of 
European Nurses in Diabetes, 2012; WHO, 2013) In Finland, DEHKO was a 
national eleven-year Development Programme for the Prevention and Care of 
Diabetes. Besides preventing type 2 diabetes, the programme focused on improving 
early diagnosis of type 2 diabetes and preventing diabetes-related complications 
(Saaristo et al., 2007). 
 
2.1.2.4 Guidance tools in health care 
 
Efforts towards rationalisation and unification of medical practices have included 
the production of guidelines, protocols and descriptions of appropriate treatment 
pathways within and between care providers, leading the way towards 
standardisation of the care process. (Groenewegen & Westert, 2004) In general, 
codes of good medical practice have a broader scope than treatment guidelines, 
which promote clinical decision making. The codes of good medical practice are 
intertwined with ethical, regulatory and educational aspects of medical practice. 
(American Medical Association, 2008; Australian Medical Council, 2013; General 
Medical Council, 2013). In Finland, no separate definitions of good medical practice 
have been issued, but such definitions are included in the national treatment 
guidelines – the Current Care guidelines produced by the Finnish Medical Society 
Duodecim – and the Physicians’ Code of Ethics produced by the Finnish Medical 
Association (The Finnish Medical Association, 2005; Käypä hoito -toimitus, 2008). 
Overall, codes of good medical practice have two functions: they provide guidance 
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for the physicians and let the public know what they can expect from physicians 
(Gill & Griffin, 2010). 
 
Clinical guidelines include syntheses of available evidence from randomised 
controlled studies, meta-analyses and observational studies via expert opinions. 
Guidelines are intended as a basis for treatment choices and do not have legislative 
power. Guidelines are expected to be easy-to-read support for the practical work of 
physicians and, when used, to decrease inconsistencies between treatment practices. 
(NICE 1990; Käypä hoito -toimitus, 2008; NICE 2013) It has also been argued that 
guidance tools are a threat to clinical decision making and professional autonomy 
(Woolf et al., 1999; Nummenmaa, 2007; de Jong, 2008). 
 
Many stakeholders have produced clinical guidelines, e.g. European and American 
specialist organisations and the international Cochrane collaboration. At the national 
level, responsibilities for the production of clinical guidelines vary between 
countries. Actors may include national medical associations, specialist associations, 
non-governmental organisations and patient organisations, including consumer 
interest groups. The number of clinical guidelines has increased substantially, yet 
there is a lack of evidence concerning multimorbidity and specific populations such 
as the elderly and women (Lewsey et al., 2000; Bartlett et al., 2005; Campbell-
Scherer, 2010; Hróbjartsson et al., 2013). The task of updating recommendations is a 
specific challenge in the production of guidelines, but current guidelines are 
commonly seen as valuable educational resources for health care (Kingston et al., 
2000). 
 
The development of clinical guidelines and progress in their usability began at 
different times in different countries. In Finland, production of the Current Care 
guidelines was initiated in 1994 by the Finnish Medical Society Duodecim. (Woolf 
et al., 1999; Kingston et al., 2000; Grol, 2001; Roine et al., 2003; Käypä hoito -
toimitus, 2008) Before that, there were 700 different recommendations or guidelines 
from various actors (Vuori, 2013; Varonen, 1997). By 2013, there were more than 
100 systematically produced Current Care guidelines (Käypä hoito -toimitus, 2008; 
Current Care editors, 2013). These guidelines are national and take European 
recommendations into account but adapt them to local circumstances (Voipio-Pulkki, 
2007; Komulainen, 2013). In the UK, the NICE guidelines include cost-
effectiveness argumentation of care in the production of the guidelines, but the 
Finnish Current Care guidelines only consider evidence on the effectiveness of the 
treatment (Grol, 2001; Käypä hoito -toimitus, 2008). Few systematic studies exist in 
Finland regarding the impact of Current Care guidelines on the quality of clinical 
practices. 
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2.1.3 Empirical studies using register-based data and examining 
changes in medical practice – literature review with 
methodological perspective  
 
A literature review on register-based studied was conducted to provide context to the 
empirical part of this study. It was intended not as a comprehensive review but to 
give a general methodological perspective on medical practices studied and registers 
used. Focusing only on register-based studies excludes medical practices that are not 
recorded in registers. Empirical reports were chosen as they were estimated to 
provide the most reliable information on the study of treatment trends. The search 
strategy of the progress of the study selection is described in Appendix 1. 
 
2.1.3.1 Medical practices examined  
 
The articles (24) reviewed focused mainly on three types of medical practices: 
medication use, operative or other specialist medical treatments performed in 
hospitals and non-specific analysis of hospitalisations. Hospitalisations were 
especially examined when analysing mental health services. Most of the articles 
analysing operative treatment focused on invasive treatment of CHD, but there was 
heterogeneity in the definitions of invasive treatment. Analysis of CHD related 
medical practices was the focus in nine of the 24 studies, mental health related 
hospitalisations were the focus in six and other hospital treatments in four; one study 
concerned avoidable hospitalisations and four studies concerned medication use. 
Studies examining medication use mainly analysed development in recommended 
treatment or changes in medication use within specific drug categories. Studies on 
operative or other in-hospital medical practices examined the use of recommended 
interventions; studies on hospitalisations concerned the increase or decrease of 
admissions or the length of stay. 
 
2.1.3.2 Type of registers used  
 
The registers used in the earlier studies were diverse, ranging from administrative 
registers to research registers, quality registers and benchmark registers. Some of the 
administrative registers used are obligatory and nationwide, like many Finnish 
registers, but there were also regional registers. Data collected specifically for 
research use utilised well-documented definitions of diagnosis, such as the ones used 
in the MONICA research. The quality registers for a specific disease might be 
obligatory or voluntary. The coverage of these registers varied. In the USA, 
benchmarking registers are voluntary and limited to a sample of hospitals.   
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2.1.3.3 Methods applied  
 
Background variables used in the analyses were related to the data available in the 
registers. The articles compared men versus women, different age groups, yearly 
cohorts, different diagnostic groups and/or different treatment groups. The studies 
were heterogeneous in the criteria of forming the groups, and therefore comparisons 
between studies are difficult. The studies reported temporal trends in medical 
practices in the USA (7), Canada (1), Nordic countries (7) and other European 
countries (8). One study was a multi-centre study including hospitals from several 
countries. The follow-up time varied from three to 28 years. 
 
Methods used in the studies varied from simple descriptive figures tabulated in 
different ways to sophisticated comparisons taking into account case-mix correction 
using regression models. The interpretation of the results of these studies is 
complicated because of underlying differences in the case mix. The patients’ ages, 
their comorbidity and the years examined influenced the outcomes. Differences in 
the methods of analysis are partly due to differences in the information available in 
each of the registers and partly due to statistical procedures available at the time of 
publishing the results. The most common procedure in case-mix correction was age 
adjustment. Some articles from the USA used case-mix corrections both at patient 
level (e.g. comorbidities, medication) and at hospital level (e.g. annual number of 
operations). Case-mix corrections used in the analyses varied according to case-mix 
relevant information obtained from the registers used for study data. Most of the 
studies were descriptive and did not allow causal inferences. 
 
2.1.3.4 Findings of the register-based studies 
 
Findings of the studies were reviewed in particular from the perspective of evidence 
based or health policy driven treatment and focused on: temporal trends in 
medication use; operative or other specific treatment in hospitals; and 
hospitalisations. Registers provide an encouraging source for repeated 
measurements and enable examining changes in medical practice over time.  
 
When examining temporal trends in changes in medical practice in mental health 
care, the researchers focused on hospitalisations and length of stay during health 
policy reform of deinstitutionalisation (Kaltiala-Heino et al., 2003; Pijl & Sytema, 
2003; Arvidsson & Ericson, 2005; Lay et al., 2007; Siponen et al., 2007). The results 
in different countries and for different diseases varied, but in many cases 
hospitalisation rates decreased or disappeared altogether, as was the case with mild 
mental disorders (Munk-Jorgensen et al., 1992). In Sweden, inpatient care decreased 
among persons with a diagnosis of schizophrenia (Arvidsson & Ericson, 2005), 
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whereas in Finland inpatient treatment of severe mood disorders increased (Kaltiala-
Heino et al., 2003).  
 
The second type of hospitalisation studies focused on avoidable hospitalisations or 
ambulatory care sensitive conditions, i.e. conditions for which hospitalisation is 
considered to be potentially avoidable through preventive care and early disease 
management, usually in a primary care setting (Page et al., 2007). One study 
reported a decrease in childhood asthma admissions (Priftis et al., 2007). 
Hospitalisations for a specific diagnosis have also been analysed. Pregnancy-related 
hospitalisations with stroke were found to increase in the USA. However, according 
to the study this was not due to medical practice variations but, instead, due to risk 
profile changes. (Kuklina et al., 2011) 
 
Research concerning medication use examined both diffusion of a new treatment 
and establishment of evidence-based medication. The introduction of antiretroviral 
therapy diminished hospitalisation dramatically among HIV-positive children in the 
USA (Kourtis et al., 2007); a sharp decline in hormone therapy prescriptions, which 
increase the risk of breast cancer, was observed among menopausal women in 
Germany (Katalinic et al., 2009); psychoactive drug use was reported to be 
relatively stable although a slight decrease of anxiolytics, which can be highly 
addictive, was observed in the Netherlands (Ravera et al., 2010); a change in 
treatment strategy was observed in the use of disease-modifying anti-rheumatic 
drugs, the use of these drugs for early-stage rheumatoid arthritis increasing 
(Rantalaiho et al., 2011); and in overall use of evidence-based medication, the 
treatment of CHD increasingly favours evidence-based treatment (Zahn et al., 2000; 
Marques-Vidal et al., 2003; Fonarow et al., 2007; Peterson et al., 2008; Fagring et 
al., 2010; Nguyen et al., 2010).  
 
Finally, some of the studies focused on the diffusion of specific treatments, such as 
safer methods for hemodialysis in Canada, where guidelines recommended the 
arteriovenous fistula as the hemodialysis access of choice. The study observed 
treatment practice change in hemodialysis; but instead of safer methods gaining 
ground, incident catheter use in hemodialysis increased, fistulas use decreased, and 
graft use remained stable. Prevalent catheter use increased, and fistulas and grafts 
decreased. The study reported significant regional variation in the use of incident 
and prevalent fistulas use. (Moist et al., 2008)  
 
In Sweden, researchers examined the increase in arthroplasty operations of the knee. 
The researchers concluded that the increase was mainly due to arthritis being 
increasingly treated by arthroplasty and that the increase was associated with 
population change. (Robertsson et al., 2000) In the USA, researchers reported an 
increasing trend in the use of cardiac catheterisation and PCI and a decreasing trend 
Background of the study 
 
THL — Research 2014•131 26 Examining time trends in medical practices using register-based data  
 
in the use of coronary bypass surgery, suggesting a change of treatment strategy in a 
less invasive direction (Peterson et al., 2008). An increasing trend towards cardiac 
catheterisation was observed in a multicentre study including data from several 
countries (Nguyen et al., 2010). A decreasing trend in hospitalisations due to 
cataract operations was found among children in Italy; ophthalmologists used an 
unusual intraocular lens implantation operation in children in one fourth of the cases 
(Ricci et al., 2009). 
 
2.1.3.5  Remarks on the register–based studies 
 
Studies focusing on change in medical practices using register-based data yield 
information about treatment trends. The medical practices in the literature review 
had three main focuses: medication use, operative or other specific hospital 
treatments, and hospitalisations. Only the studies on medication use provided 
information on medical practices outside secondary or specialised medical care in 
hospitals.  
 
The coverage of the source registers varied from very small area level databases to 
comprehensive national-level registers, the data being collected in administrative or 
project-driven work. There were both voluntary and compulsory registers. These 
context-specific features had an impact on the opportunities to report and the 
methods available. The case-mix correction used most widely was simple age 
adjustment, and socioeconomic factors were taken into consideration occasionally. 
The role of case-mix in the interpretation of the results is essential. Overall, the 
complexity of the data and the methods used in the analysis of trends in medical 
practices seemed to increase over time. 
 
Three different research interests could be detected in the studies. Firstly, medical 
practices and their trends were studied when new health technology (drug or surgical 
procedure) was adopted. Secondly, studies were conducted when evidence on 
adverse effects of some medical practice had accumulated. A third interest was to 
monitor the diffusion of evidence-based medical practice or effects of health policy 
steering mechanisms. The majority of the studies examining diffusion of health 
technology focused on the change in medical practices in CHD, where progress of 
evidence-based drug therapy and use of the less invasive coronary revascularisation 
technique had become more widespread. An example of the second type of interest 
is hormone therapy. When increased risk of breast cancer was found to be associated 
with hormone therapy among menopausal women, real-world monitoring of 
treatment trends and differences between areas reported a sharp decline in hormone 
therapy prescriptions. An example of the third type of interest is the policy reform in 
the treatment of mental disorders. Many countries have enacted a health policy 
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reform to deinstitutionalise mental health patients by reducing resources for hospital 
treatment. The studies reported not only diminishing hospitalisations but changes in 
the length of stay. The result of the diminishing hospitalisations was constant across 
studies, but results concerning length of stay and services replacing hospital care 
differed. It is difficult to compare the results of different studies even if they concern 
the same medical practices, since they use different methodologies and different 
study settings and come from different points in time. 
 
The landscape provided by this literature review suggests that studies on trends in 
medical practices using register-based data yield relevant information about health 
care. Studying trends provides an opportunity to assess how the use of health 
technology (e.g. drugs, surgical operations) has changed in real-world treatment 
practices: whether the trends are increasing or decreasing and whether the treatment 
is well-established or fluctuating. For clinicians, studies on trends in medical 
practices can provide an overall picture of possible undertreatment or overtreatment 
of a disease, an overview of whether the medical practice studied replaces earlier 
medical practice or adds to it, and, if the dataset is large and representative enough, 
an impression of whether medical practices are targeted according to need. The 
studies provided information on aggregated trends in medical practices in the 
context of changes in resources used, in health policy and use of clinical guidelines 
and diffusion of specific medical practices. In summary, the studies on trends in 
medical practices are at least partly context-specific but may be used for assessing 
the functioning of health care, for benchmarking practice and for planning of service 
delivery.   
 
2.2   Factors contributing to medical practices in coronary 
heart disease care in Finland from the mid-1990s  
2.2.1 Resource increase in coronary revascularisations  
 
In Finland, two policy measures have had the effect of increasing resources in 
coronary revascularisation operations: an increase in investment in the operation in 
hospitals, and an increase in the number of cardiologists.  
 
In the late 1980s and early 1990s, assessment for the need for services with new 
surgical opportunities to treat CHD was considered to be important, because CHD 
mortality among the Finnish population was one of the highest in international 
comparison (Rönnemaa et al., 1991; Salomaa et al., 1996; Melkas, 2013). This 
assessment was made by working groups at the National Board of Health and the 
subsequent National Board of Welfare and Health (Pyörälä & Olkinuora, 1986; 
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Alanko & Hokkanen, 1991; Idänpään-Heikkilä et al., 1994). Later, a working group 
for coronary heart disease nominated by STAKES reassessed the need for coronary 
revascularisation operations and gave recommendations on quality indicators 
(Pyörälä & Olkinuora, 1986; Alanko & Hokkanen, 1991; Idänpään-Heikkilä et al., 
1994).  
 
In 1993, the annual need for angioplasty (PCI) and bypass surgery procedures 
(CABG) in the Finnish population was estimated to be 3 000–4 000 higher than the 
supply for PCIs and 4 500–5 000 higher than the supply for CABGs. At that time, 
Finnish hospitals performed 1 400 PCIs and 3 700 CABGs annually (Idänpään-
Heikkilä et al., 1994). In 2001, the supply of PCI was 4 000, and a government 
expert group recommended a substantial increase of PCI treatments over to 10 000. 
(Tierala, 2001) Thereafter, the number of PCI procedures has increased (Figure 1). 
 
In 1995–2001, the population rates of PCI in Finland were average compared with 
other European countries. In 2002–2003, the rates increased considerably, from 655 
to 1 276 per one million people. (Allender et al., 2008) Unfortunately, the inter-
country comparability is limited due to lack of information on private hospitals in 
some countries, which partly explains the differences in statistics. However, the 
statistics do indicate substantial variation in PCI rates between countries. The 
European cardiovascular disease statistics did not report the numbers of CABG. 
Compared to the USA and Canada, the number of coronary revascularisations 
performed in Finland was lower. (Sydän- ja verisuonitautien ja diabeteksen 
asiantuntijatyöryhmä, 2005; Alter et al., 2006; Lucas et al., 2006) 
 
In 1997, the number of cardiologists in Finland was 16 per one million residents. 
The density of cardiologists was among the lowest in the EU countries (the range 
being from 170 in Greece to 8 in the UK) and lower than in the USA (70). (Block et 
al., 2000) However, according to the statistics of the Finnish Medical Association, 
the number of cardiologists in Finland has been consistently increasing. In 2012, 
there were 225 cardiologists of working age in Finland, or 41 per one million 
residents (The Finnish Medical Association, 2013) (Figure 2). 
 
To conclude, trends in coronary revascularisation operations since the mid-1990s 
showed gradual reduction in the numbers of CABG and marked increase and later a 
levelling off in PCI. Over a twelve-year period (2000–2011), there was a 130% 
increase in the number of PCI procedures and a 46% decrease in CABG. At the 
same time, the number of cardiologist of working age increased by 60%. In 2011, 
there were 2 527 CABG procedures, 8 308 PCI procedures and 215 cardiologists.  
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Figure 2. The number of coronary revascularisations in Finland (THL, 2013).  
 
Figure 3. The number of cardiologists of working age in Finland (The Finnish 
Medical Association). 
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2.2.2 Changes in reimbursement policy and lipid-lowering medication price  
 
As a response to increasing pharmaceutical expenditure, generic substitution was 
introduced in 2003 (Finlex, 80/2003; Mossialos & Srivastava, 2008). To facilitate 
the use of needed medication among patients with CHD, a change in reimbursement 
policy for lipid-lowering drugs was introduced in 2000. Generic substitution was 
followed by intense price competition, and the price of lipid-lowering drugs has 
decreased since then.  
 
In Finland, generic substitution means that the dispensing pharmacy has an 
obligation to offer a cheaper interchangeable product as a substitute for a prescribed 
medicine. Efforts to introduce a legislative amendment enacting obligatory generic 
substitution succeeded in April 2003. This compulsory procedure was introduced to 
control public expenditure by promoting more competition between pharmaceutical 
companies. (Keskimäki & Vuorenkoski, 2003; Pekurinen & Häkkinen, 2004; 
Ahonen & Martikainen, 2005) A voluntary generic substitution was in effect in 
1993–1996 and generic prescribing in 1996, but voluntary actions had no 
considerable effect on expenditure (Keskimäki & Vuorenkoski, 2003; Pelkonen, 
2006). Compulsory generic substitution was received well, and at that time only 
10% of patients and very few physicians refused the potential prescription 
substitutions. The procedure includes an option for the prescribing physician to 
decline generic substitution for medical reasons and for the patient to decline 
substitution without giving any reason for it and still be reimbursed by the National 
Health Insurance according to the actual costs of the prescription. (Keskimäki & 
Vuorenkoski, 2003; Heikkilä & et al 2007; Vuorenkoski, 2008)  
 
More recently, in 2006 a reference price system based on generic pharmaceuticals 
was introduced. The system establishes a common reimbursement level or reference 
price for a group of interchangeable medicines. If a pharmaceutical is priced above 
the reference price, the patient pays the difference between the price of the 
pharmaceutical and the reference price, in addition to any other co-payments (Dylst 
et al., 2012). The Pharmaceuticals Pricing Board sets and updates the reasonable 
wholesale prices four times a year. If a certain medicine is not confirmed as 
reimbursable, the patients have to pay the full price. The Pharmaceuticals Pricing 
Board operates under the Ministry of Social Affairs and Health. (STM, 2013) 
 
For patients, reimbursement for medicine expenses is available for prescribed 
medicines for treatment of an illness. There are three reimbursement categories, the 
reimbursement covers necessary medicine expenses, and the purchase is for three 
months at a time. In general, the basic reimbursement covers around half of the cost 
of prescribed medicine to the patient through national health insurance, but in regard 
Background of the study 
 
THL — Research 2014•131 31 Examining time trends in medical practices using register-based data  
 
to certain chronic diseases the reimbursement of selected medicines is increased. In 
the case of life-saving drugs, such as insulin or thyroxin, the reimbursement to the 
patient covers the entire cost. The medical criteria required for entitlement to a 
higher reimbursement rate are set out by the SII. The medical certificate for a higher 
rate of reimbursement is based on examinations performed by a physician. (National 
Agency for Medicines & Social Insurance Institution, 2001; Social Insurance 
Institution in Finland, 2013) 
 
In the mid-1990s, when lipid-lowering drugs were introduced in Finland, they were 
an expensive medication for the patients (Strandberg et al., 1997). The price of lipid-
lowering medication decreased by 78% over a twelve-year period (2000–2011); for 
patients, the decrease in costs was 77% (Figure 4). In 2011, the number of lipid-
lowering medication recipients was 666 590, 200% more than in 2000. (Figure 5).  
 
Table 1 presents policy changes in reimbursement for lipid-lowering medication for 
three patient groups: patients with familiar hypercholesterolemia, patients with CHD 
and patients with diabetes. Lipid-lowering medication costs are reimbursed for 
persons with familiar hypercholesterolemia according to a higher rate of 
reimbursement, and for persons with diabetes according to basic reimbursement. 
The greatest change in reimbursement for lipid-lowering medication took place in 
2000 when patients with CHD were awarded a higher rate of reimbursement.  
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Table 1. Policy changes in the reimbursement for lipid-lowering medication. 
Reimbursements of lipid-lowering medication Year Policy change  
Patients with 
familiar hyper- 
cholesterolemia 
Patients with 
CHD  
Patients with 
diabetes  
 
 
1998 
Voluntary 
generic 
prescribing in 
effect since 1993  
Introduction of a 
two-year delay 
period for 
applying higher 
reimbursements 
(75% / 100%) for 
new medicines 
75% 
reimbursement,  
fixed copayment 
EUR 5 / 
prescription 
50% 
reimbursement, 
fixed copayment 
EUR 10 / 
prescription 
50% 
reimbursement, 
fixed 
copayment 
EUR 10 / 
prescription 
2000 NA  no changes 75% 
reimbursement,  
fixed copayment 
EUR 5 / 
prescription  
no changes 
2003 Introduction of 
mandatory 
generic 
substitution by 
pharmacist  
no changes no changes no changes 
2006 Expensive statins 
(rosuvastatin) 
reimbursed only 
when less 
expensive ones 
are proved to be 
ineffective or not 
tolerated 
72% 
reimbursement  
fixed copayment  
(EUR 1.50/item) 
after the  
annual ceiling* 
72% 
reimbursement  
fixed copayment 
(EUR 1.50/item) 
after the annual 
ceiling* 
42% 
reimbursement  
fixed 
copayment 
(EUR 
1.50/item) after 
the annual 
ceiling* 
2012 Restriction of 
rosuvastatin was 
removed 
no changes no changes no changes 
*Annual ceiling introduced in 1986, and since 1994 it has remained between  
EUR 614 and EUR 617. 
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Figure 4. The average cost (EUR) of lipid-lowering medication (C10) in Finland, 
divided into the reimbursement by SII and cost to the patient. (SII, 2013) 
 
Figure 5. Number of recipients of lipid-lowering medication (C10) in Finland. (SII, 2013) 
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2.2.3 National diabetes programme (DEHKO)  
 
Since the 1990s, the challenge presented by diabetes to public health and health care 
systems has become widely recognised. The number of new diabetes cases has 
increased, which was associated with an epidemic of overweight (Wild et al., 2004). 
Diabetes and CHD share many risk factors: overweight, high saturated fat intake, 
smoking and a sedentary life style. The diseases often occur simultaneously. 
(Haffner et al. 1998; Juutilainen et al. 2005; Sydän- ja verisuonitautien ja 
diabeteksen asintuntijaryhmä 2005; Reunanen, 2006a; Reunanen, 2006b; 
Suomalaisen Lääkäriseura Duodecimin ja Suomen sisätautilääkäreiden yhdistyksen 
ja Diabetesliiton asettama työryhmä 2007; Suomalaisen Lääkäriseura Duodecimin ja 
Käypä hoito -johtoryhmän asettama työryhmä 2012) In Finland, research evidence 
repeatedly suggested that the glycemic control of diabetes as well as prevention of 
comorbidities had to improve, but in the 1990s the number of diabetes patients was 
not monitored (Kangas et al., 1996; Valle et al., 1997; Reunanen et al., 2000). It has 
later been shown that the number of diagnosed diabetes cases increased steadily 
from the mid-1990s, the number of people diagnosed with diabetes in the population 
being about 370 000 in 2011 (Figure 6).  
 
The national diabetes programme for Finland was launched in 2000. The programme 
was called the Development Programme for the Prevention and Care of Diabetes 
(DEHKO), and its running time was eleven years. The Finnish Diabetes Association 
was the initiator, organiser and coordinator of the programme. Co-operation was 
established with clinicians, public authorities, government agencies and NGOs. 
(Aarne et al., 2011) DEHKO had an implementation project, FIN-D2D (2003–2008), 
the main objective of which was to develop practices for the prevention and early 
treatment of diabetes and cardiovascular diseases. (The Finnish Diabetes 
Association, 2003; Saaristo et al., 2009) 
 
The DEHKO programme focused on the prevention of diabetes and underlined two 
complementary approaches: the population strategy and high-risk strategy. The 
population strategy considered the management of diabetes as a community 
challenge and focused on preventing type 2 diabetes as well as improving early 
diagnosis of the disease. It included broad targets to improve population health, such 
as reducing obesity, increasing physical activity and encouraging healthy eating 
habits. A validated one page questionnaire, ‘The Finnish diabetes risk score’, for 
assessing risk for the disease was disseminated. The high-risk strategy was applied 
to the prevention of diabetes-related complications, i.e. to limiting the progressive 
nature of type 2 diabetes and its cardiovascular complications. The high-risk strategy 
was based on experiences from the Finnish Diabetes Prevention Study, which had 
shown that changes in lifestyles enable prevention of type 2 diabetes (Tuomilehto et 
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al., 2001; The Finnish Diabetes Association, 2003). These findings were replicated 
in other randomised clinical studies (Norris et al., 2005). From the patient’s 
perspective, CHD complications decrease quality of life (Wändell, 2005), 
emphasising the importance of prevention of these complications in the management 
of type 2 diabetes. The motivation behind DEHKO and later FIN-D2D was that 
diabetes was increasingly seen as a cardiovascular disease (Haffner et al. 1998). 
Therefore, treatment of diabetes focused increasingly on preventing coronary 
complications.  
 
The assessment of DEHKO reported progress in the treatment: diagnosis of diabetes 
was made earlier, and the recommended metformin treatment increased among type 
2 diabetes patients. However, reduction of the risk of arterial disease remained low 
among patients with diabetes. (Tuomola et al., 2011)  
 
 
 
Figure 6. The prevalence of diabetes measured at the last day of the year 
according to FinDM II data. (THL, 2013)  
2.2.4 Current Care guidelines  
 
Current Care guidelines are produced by the Finnish Medical Society Duodecim in 
co-operation with various medical specialist societies. These guidelines aim to 
provide consistent information to support treatment decisions. Public funding for the 
Current Care guidelines is provided by the Ministry of Social Affairs and Health, SII, 
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and the Finnish Medical Society Duodecim, and the use of funding is controlled by 
the National Institute of Health and Welfare. The support from the Ministry of 
Social Affairs and Health is motivated by concern over variations in quality in 
clinical practice. (Vainikainen, 2005; Vainikainen, 2009; Komulainen)  
 
Before the production of Current Care guidelines started in 1995, several clinical 
guidelines or recommendations related to the treatment of coronary heart disease 
among persons with diabetes had been published in Finland. The first national 
treatment guideline for type 2 diabetes was published by the Finnish Diabetes 
Association in 1994 (Uusitupa et al., 1994). In the same year, the European 
recommendations for prevention and treatment of coronary heart disease were issued; 
they were disseminated two years later through the Finnish Medical Journal 
(Suomen Sisätautilääkärien Yhdistyksen, Suomen Kardiologisen Seuran, Suomen 
Verenpaineyhdistyksen, Kunnallislääkärityhdistyksen, Suomen Teollisuuslääke-
tieteen Yhdistyksen ja Suomen Sydäntautiliiton työryhmä, 1996). Later in the early 
2000s, the Finnish Medical Association Duodecim published national guidelines on 
‘Treatment of hypertension’, ‘Acute coronary syndrome’ and ‘Dyslipidemias’ 
(Suomen Verenpaineyhdistys ry:n asettama työryhmä, 2002; Suomen Kardiologisen 
Seuran asettama työryhmä, 2003; Suomen Sisätautilääkärien Yhdistys ry:n asettama 
työryhmä, 2004; Suomen Sisätautilääkärien Yhdistys ry:n asettama työryhmä, 2004). 
The European recommendations for prevention and treatment of coronary heart 
disease were updated and translated into Finnish in 2004 and in 2008 (Suomen 
Sisätautilääkärien Yhdistyksen, Suomen Kardiologisen Seuran, Suomen 
Verenpaineyhdistyksen, Kunnallislääkärityhdistyksen, Suomen Teollisuuslääke-
tieteen Yhdistyksen ja Suomen Sydäntautiliiton työryhmä, 1996; De Backer et al., 
2004; Euroopan kardiologinen seura ja työryhmä, 2008). All the guidelines included 
general recommendations, and some gave specific recommendations for important 
subgroups, including patients with diabetes (Lugtenberg et al., 2011).  
 
Thereafter the guidelines have been updated. The Current Care guideline for 
diabetes was published in 2007 and updated in 2012 (Suomalaisen Lääkäriseuran 
Duodecimin ja Suomen Verenpaineyhdistys ry:n asettama työryhmä, 2005; 
Suomalaisen Lääkäriseuran Duodecimin, Suomen sisätautilääkäreiden yhdistyksen 
ja Diabetesliiton lääkärineuvoston asettama työryhmä, 2007; Suomalaisen 
Lääkäriseuran Duodecimin ja Suomen Kardiologinen Seura ry:n asettama työryhmä, 
2009; Suomalaisen Lääkäriseuran Duodecimin ja Suomen Sisätautilääkärien 
Yhdistys ry:n asettama työryhmä, 2009; Suomalaisen Lääkäriseuran Duodecimin ja 
Suomen Kardiologisen Seuran asettama työryhmä, 2011). In the development of 
Current Care guidelines, synchronisation and harmonisation with international care 
guidelines has been the usual course of action (Voipio-Pulkki, 2007). 
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The treatment recommendations for CHD among patients with diabetes can be 
generally summarised as follows: Firstly, the guidelines have described with a high 
level of consistency that there is a need for drug use to prevent CHD and its 
complications among patients with diabetes; usually, anti-hypertensive drugs and 
lipid-lowering medication have been recommended. Secondly, while evidence for 
coronary revascularisation being the best treatment option for diabetes patients has 
been somewhat weak, the recommendations suggest based on the results and the 10-
year follow up of the Bypass Angioplasty Revascularisation Investigation trial that 
CABG has better long-term treatment outcomes than PCI among patients with 
diabetes (The BARI Investigators, 2007).  
 
The latest guidelines on diabetes, pre-diabetes and cardiovascular diseases (2013) by 
the European Society of Cardiology (ESC) underline consistently that patients with 
diabetes are considered to be at high cardiovascular risk. Moreover, patients with 
diabetes and cardiovascular disease (MI, angina pectoris) are at a very high risk of 
recurrent cardiovascular complications. In patients with coronary artery disease and 
diabetes, medical therapy (ACE inhibitors or angiotensin receptor blockers; beta 
blockers; statins; aspirin) is recommended. When invasive treatment is needed, the 
guideline recommends informing the patient about the risks and benefits of CABG 
vs. PCI and then recommends shared decision-making within the context of the 
patient’s preferences (ESC, 2013). In the Finnish Current Care guideline for 
Diabetes and in the American Diabetes Association’s standards for medical care in 
diabetes, recommendations for medical therapy among patients with diabetes and 
CHD are similar to those of the ESC. (ESC, 2013; Suomalaisen Lääkäriseuran 
Duodecimin, Suomen Sisätautilääkäreiden yhdistyksen ja Diabetesliiton 
Lääkärineuvoston asettama työryhmä, 2013; American Diabetes Association, 2014) 
The American Diabetes Association requires beta blockers for patients with a prior 
MI. (American Diabetes Association, 2014) All in all, the focus of diabetes 
treatment should change from glycemic control to improving long-term survival 
related to prevention and treatment of CHD (Wang, 2012). 
 
2.2.5 Remarks on factors associated with coronary heart disease care  
 
In Finland, several factors influencing treatment practices of CHD in the 1990s and 
2000s can be identified. Resources for invasive treatments of CHD increased along 
with the numbers of cardiologists. At the same time, new pharmaceutical treatments 
emerged, and extension of special reimbursement rights for lipid-lowering 
medication costs to include patients with CHD was enacted in 2000. Also, 
obligatory generic substitution was launched in 2003. A programme for prevention 
and treatment of diabetes as well as for prevention of cardiovascular comorbidities 
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was conducted in 2000–2010. To improve CHD treatment in Finland, Current Care 
guidelines have been published and updated. 
 
Overall, these Finnish experiences show progress in the adoption of health 
technologies in medical practice in the treatment of CHD. Firstly, resources 
allocated to coronary revascularisations have increased, as has the number of PCI 
procedures. Secondly, the cost of lipid-lowering medication has decreased overall, 
and a specific health insurance reform targeted to decrease CHD patients’ lipid-
lowering medication costs was launched. Concurrently, comprehensive actions in 
the prevention of diabetes and prevention and treatment of CHD among persons 
with diabetes took place in the Finnish health care system, resulting in a higher 
awareness in early diagnosis and treatment of diabetes and its complications.  
 
2.3 Conclusions from earlier literature  
 
Medical practice variation is a useful concept for assessing health care. Variations in 
medical practice between geographical areas have been demonstrated in a large body 
of literature (Keskimäki et al., 1994; Black et al., 1995; Birkmeyer et al., 1998; 
Dunn et al., 2005; Lysdahl & Borretzen, 2007; Bhatnagar et al., 2010; Maheshwari 
et al., 2011; Pearce-Smith, 2011; Welch et al., 2011). Variations in health care use 
are partly due to different preferences among patients concerning medical treatment 
and differences in morbidity, but partly the variation is associated with available 
health care resources or the practice patterns of physicians (Andersen & Mooney, 
1990; McPherson, 1990; Wennberg, 2002). Shifting the focus from regional 
variation to changes over time yields information on increasing and decreasing 
trends in specific medical practices and on whether a treatment is well-established or 
fluctuates.  
 
Many factors in society and the health care system and their development are 
associated with these trends of medical practice change over time. Identified factors 
− legislation, resources, adoption of health technology, policy measures and clinical 
guidelines – operate on several levels from public policy down to the practice of 
individual actors in health care. These factors can be summarised by their function: 
regulation, modernisation and standardisation (de Jong, 2008).  
 
The literature review conducted provides a landscape of the ways in which medical 
practices changes over time have been studied before. Based on register data, earlier 
studies present information on medication use, operative treatments delivered in 
hospitals and hospitalisations at times when a new health technology was initialised, 
or when evidence of adverse effects of a medical practice had accumulated, or when 
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evidence-based guidelines or health policy steering mechanisms were launched. It 
can also be assumed that medical practices related to CHD treatment illustrate 
changes in medical practice in Finland over time more generally. 
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3 The aims of the study  
This study focused on changes in medical practice at the level of the health care 
system. It is register-based, taking the viewpoint of treatment of CHD among 
patients with diabetes within health services as a case study of changes in medical 
practices. The general aim was to examine temporal trends in CHD treatment 
practices among patients with diabetes. Two medical practices were examined, 
namely medication to prevent CHD complications and coronary revascularisations.  
 
 
More specifically, the aims of the sub-studies were:  
 
I To examine differences in the use of medication to prevent new cardiac 
events among newly diagnosed CHD patients with diabetes compared to 
non-diabetic patients and whether the treatment trends in medication vary 
between socioeconomic groups.  
 
II To examine differences in the use of lipid-lowering medication among 
incident diabetes population and whether the annual trends vary by 
socioeconomic group. The study further examined whether these trends are 
modified by comorbidities.  
 
III To analyse whether a diagnosis of diabetes modifies access to 
revascularisation among newly diagnosed CHD patients at the time of 
increasing resources for revascularisations. The study further describes 
changes in trends in revascularisations in this patient group and the 
possible socioeconomic variation in treatment trends.  
 
IV To examine differences in pathways to revascularisation among patients 
with diabetes versus other non-diabetic CHD patients, trends over time in 
these pathways and the possible modifying effect of comorbidities on the 
pathways to revascularisation.   
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4 Data and methods 
The present study draws on register-based data and presents four longitudinal sub-
studies using yearly cohorts of persons with diabetes and/or CHD. In each sub-study, 
the study design was tailored to answer the specific research questions and incident 
or prevalent patient populations were defined for each of the studies.  
 
4.1 Data  
 
The research data sets comprise data obtained from registers maintained by the 
National Institute for Health and Welfare (THL), the Social Insurance Institution of 
Finland (SII) and Statistics Finland. The registers used include the Finnish Hospital 
Discharge Register on hospital care, the register on purchases of medicines 
reimbursed by the National Health Insurance and employment statistics. The 
registers are statutory, and the information is regularly collected and updated at the 
individual level. The compilation of the datasets used in this study is described in 
detail elsewhere (Niemi & Winell, 2005; Kajantie et al., 2006; Seppälä et al., 2008; 
Sund & Koski, 2009; Peltola et al., 2011). The datasets for each study are 
summarised in Appendix 3. 
 
Information on diagnosed diseases utilised data from one or more of the following 
register sources: Hospital Discharge register, Benchmarking database, Social 
Insurance Institution register data on persons eligible for special reimbursement of 
medicine costs due to certain chronic disease, and reimbursed purchases of 
prescription medicines.  
 
The Finnish Hospital Discharge Register is maintained by the National Institute for 
Health and Welfare (THL). Data in the register are mainly based on individual-level 
discharge reports collected annually from all public and private hospitals. The 
Hospital Discharge Register used the 9th revision of the International Classification 
of Diseases (ICD) until 1996 and has used the 10th revision since then (Stakes, 
1999a; Stakes, 1999b). Surgical operations were classified according to the 
classification of procedures by the Finnish Hospital League until 1996, and 
thereafter according to the Nordic Medicostatistical Committee classification 
(Finnish Hospital League, 1983; NOMESCO, 1996).  
 
The Social Insurance Institution is the registration authority for the special 
reimbursement register and for the Finnish database on all reimbursed drug 
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purchases (Martikainen, 2008; Social Insurance Institution in Finland, 2009a). 
Reimbursed purchases of prescription medicines cover purchases in outpatient care, 
and the data can be used to represent medicine use even though some patients might 
not use all medicines they have purchased. (Social Insurance Institution in Finland, 
2009b) Medicines were coded according to the Anatomical Therapeutic Chemical 
(ATC) system in the Social Insurance Institution database on all reimbursed drug 
purchases (WHO, 2006). The Special Reimbursement Register includes information 
on individuals who are entitled to reimbursement of medication for certain chronic 
diseases. The Special Reimbursement Register covers approximately 50 diseases; in 
the adult population, the most common diseases that are eligible for special 
reimbursement are chronic hypertension, diabetes and asthma.  (National Agency for 
Medicines & Social Insurance Institution, 2003) 
 
Information of sociodemographic factors was obtained from the annual employment 
statistics maintained by Statistics Finland. Information on income was derived from 
national tax register data. (Statistics Finland, 2013) 
 
4.1.1 Definition of the cases 
 
Persons with diabetes 
 
The case definitions of diabetes patients were based on the Social Insurance 
Institution register data on special reimbursement rights for medicine costs, the 
prescription register and the Hospital Discharge Register. Persons eligible for 
special reimbursement for medication costs for diabetes medication (Finnish code 
103), those who had bought diabetes medicines (ATC A10) and those with inpatient 
care due to diabetes (ICD-9 250; ICD10 E10; E11; E13; E14) were defined as 
having diabetes. Patients with gestational diabetes only were excluded from the 
analyses. One study (I) concerned an undivided group of diabetes patients, while the 
others defined diabetes type in three ways: Firstly, the distinction between type 1 
and type 2 diabetes was based on information of delivered prescriptions of diabetes 
medicine and age at the onset of diabetes. Diabetes was defined as type 1 if the onset 
of the disease was before the age of 30 years; for type 2 diabetes the age limit was 
40 years or older. Diabetes type for individuals in the age bracket 30 to 39 was 
defined as unknown, and they were excluded from the analysis by diabetes type (III). 
This age-based definition of diabetes type draws from an epidemiological study 
conducted in Western Finland (Eriksson et al., 1992). Secondly, the definition of 
diabetes type was based mainly on information of prescriptions of diabetes medicine 
and identified persons with insulin-dependent diabetes (IDD) and non-insulin-
dependent diabetes (NIDD). The insulin-dependent group was defined by 
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continuous insulin usage and no purchases of other type of diabetes medication (IV). 
Later, this definition title was found to be misleading among clinicians and changed. 
For the third definition, non-insulin-treated diabetes mellitus (NITDM) and insulin 
treated diabetes mellitus (ITDM) were used (II). These definitions tailored for 
Finnish register-based data were developed by the FinDM II steering board (Sund & 
Koski, 2009). 
 
Persons with CHD  
 
CHD cases were defined using information from several registers, and information 
of CHD diagnosis or treatment and special reimbursement rights for CHD medicines 
was used. Firstly, newly diagnosed CHD patients were identified in hospital 
inpatient treatments due to CHD using information of MIs (ICD9-codes 410, 
ICD10-codes I21–I22) and coronary revascularisations. Moreover, information of 
CHD diagnosis entitling a patient to special reimbursement of medicine costs (206) 
was used. To ensure that the CHD patients were new cases, the Hospital Discharge 
Register was searched for previous entries back to 1990 (I, III). The longitudinal 
data enabled accounting for the time of onset of CHD. The total population of 
persons diagnosed with diabetes was stratified by CHD status indicated by eligibility 
for special reimbursement for CHD medicines (206) or hospital inpatient treatment 
due to CHD. Persons with diabetes were classified into three groups (II): (1) persons 
with diabetes and no information on CHD before or during the first year after 
diabetes diagnosis, (2) persons with CHD at least one year before diabetes diagnosis, 
and (3) persons with coincident diagnosis of CHD and diabetes. Besides these, a 
total population of persons with the history of first coronary revascularisation 
procedure was used (IV). This CHD population represented the hospital population 
which was identified to have a need for and to be eligible for revascularisation.        
 
Other factors 
 
The results were mainly presented separately for men and women. The age bracket 
of the studies was 40 to 79 years of age. In addition, in the second sub-study of 
newly diagnosed diabetes patients the age group 30–40 was included, and in the 
fourth sub-study with total population of coronary revascularisations no upper age 
limit was imposed. Age was taken into account as a categorical factor. 
Socioeconomic status was measured using frequently used classifications, including 
education (basic, secondary, higher) and income quintile. The three categories of 
education were based on the length of education obtained from the Register of 
educational achievement. The basic education category corresponds to less than 10 
years of education. The intermediate or secondary education category was defined as 
secondary school and vocational training or upper secondary school matriculation, 
requiring 10–12 years of education. The category of higher education includes 
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people with a university degree or qualification requiring 13 or more years of 
education. Tax register-based income data were adjusted for family size using the 
OECD equivalence scale, where the first adult is weighted as 1.0, other adults as 0.7 
and children under 18 years old as 0.5 (I, III) (OECD, 2005). Income quintiles were 
derived from the general population, and those with no recorded income were 
assigned to the lowest income group. To avoid indirect identification, the income 
variables were edited by Statistic of Finland so that the maximum personal net 
income was rounded to EUR 50 000 and the maximum family net income to EUR 
100 000 per year. 
 
Information on patients’ comorbidity was collected from drug reimbursements and 
hospital data. Information on comorbidities was used to standardise for case-mix 
between population groups (e.g. CHD patients with and without diabetes). Two 
studies (I, III) used a modification of Elixhauser’s coding algorithms based on ICD 
codes (Quan et al., 2005). In two studies (II, IV), comorbidity was controlled for 
using a method developed for Finnish register studies (Lamers & van Vliet, 2004; 
Quan et al., 2005; Juntunen et al., 2008; Peltola et al., 2011) .  
 
Patient populations in sub-studies 
 
In the first sub-study, a cohort of newly diagnosed CHD patients with and without 
diabetes in 1997–2002 (5 220 men and 4 046 women with diabetes, 38 280 men and 
27 078 women without diabetes) was examined to investigate the use of medication 
to prevent cardiac complications. Furthermore, medication use was examined by 
socioeconomic group. In the second sub-study, newly diagnosed diabetes patients in 
2000–2006 (67 357 men, 53 696 women) were analysed in annual cohorts to assess 
the use of lipid-lowering medication after diabetes diagnosis. The study examined 
whether sex, age or income-related inequalities existed in the use of lipid-lowering 
medication and whether these differences changed over time. The onset of CHD was 
also taken into account. Moreover, the study described change in lipid-lowering 
medication use at the time of diabetes diagnosis by comparing the level of use after 
the diagnosis to that before it.  
 
In the third sub-study, a cohort of newly diagnosed coronary patients with and 
without diabetes in 1995–2002 (7 333 men and 6 258 women with diabetes, 57 294 
men and 39 945 women without diabetes) was used to investigate access to first 
coronary revascularisation and whether this changed over time. Access to first 
coronary revascularisation was examined also by socioeconomic group. In the fourth 
sub-study, a cohort of patients who underwent their first coronary revascularisation 
in 1998–2007 was analysed to elaborate differences in coronary care by analysing 
treatment pathways to first revascularisations among patients with diabetes (11 641 
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men, 5 904 women) versus other CHD patients (44 498 men, 16 731 women). A 
summary of datasets and patient populations is presented in Appendix 4. 
 
4.2 Statistical methods  
 
Methods were tailored in each sub-study to answer specific research questions. All 
sub-studies were longitudinal. Sub-studies I, II, and III measured CHD treatment 
among newly diagnosed patient populations, while and sub-study IV looked back at 
CHD events that had already taken place before the first coronary revascularisation.  
 
To investigate the use of medication preventing cardiac complications, filled 
prescriptions of medication were examined (I). Filled prescriptions, i.e. purchases of 
prescription drugs, were collected from the registers using ATC codes (C07, C09A, 
C09B, C09C, C09D and C10). Descriptive analyses, crude and age-adjusted rates of 
cases in this medication use were calculated first. Secondly, relative differences 
were examined using regression models and adjusted for age, income, MI (ICD9-
codes 410, ICD10-codes I21–I22), year and previous use of medication. Thirdly, the 
study examined whether the use of medication varied within socioeconomic groups 
and between time periods. 
 
To examine lipid-lowering medication use among patients with newly diagnosed 
diabetes in the longitudinal data, careful construction of variables was carried out 
(II). The first observation window was the medication status defined as filled 
prescriptions 24–30 months before the diabetes diagnosis, while the second 
observation window was 6–12 months after diabetes diagnosis. Because CHD is the 
main indication for lipid-lowering medication, patient groups were defined by the 
onset of CHD in relation to diabetes onset, separating new cases and cases with 
CHD before the onset of diabetes. In the descriptive analysis, proportions of persons 
were calculated in the second observation window for each annual cohort of new 
diabetes cases divided by patient groups and stratified by income quintile. 
Furthermore, logistic regression models were used to estimate the association of 
diabetes diagnosis with the increase in filled prescriptions after the diagnosis as 
compared to those before the diagnosis. The models were adjusted for age, sex, 
comorbidities, and the expected overall increase in medication use.  
 
Differences in trends in access to first coronary revascularisation among newly 
diagnosed CHD patients with and without diabetes were examined in sub-study III. 
Firstly, trends in access to first revascularisation were estimated by calculating age-
adjusted rates for CABG and PCI per 1 000 person-years for the beginning (1995–
1996) and the end (2001–2002) of the study period. Secondly, using Cox’s 
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regression models, time trends in operations were analysed adjusting for age, time 
period and history of MI. Both analyses were performed separately for men and 
women with and without diabetes and by income quintile. Separate Cox’s regression 
models adjusted for confounders were performed for access to first PCI or to first 
CAGB separately for diabetes type 1 and 2. 
 
Sub-study IV investigated whether treatment pathways leading to first coronary 
revascularisation differed between patients with and without diabetes. After defining 
treatment pathways, descriptive figures were calculated for all CHD patients with a 
history of first revascularisation. Secondly, change in medical practice was 
described first as proportions of revascularisations at the first treatment period, and 
second, as proportions of revascularisations after suboptimal treatment pathways. 
Suboptimal treatment pathways were defined as pathways containing several cardiac 
emergency hospitalisations. Finally, differences between patient groups were 
examined using a logistic regression model adjusting for age, comorbidity and 
region (Berlin et al., 1999; Juntunen et al., 2008; Sund & Koski, 2009; Peltola et al., 
2011).  
 
4.3 Ethical issues 
 
Finland has data protection legislation, which allowed the collection and use of these 
data for statistical and scientific purposes. The current study was conducted in 
several large research projects. The data linkages were performed by the competent 
statistical authorities and approved by the office of the Finnish data protection 
ombudsman. The research group received anonymised data. The data protection 
legislation and corresponding regulations and guidelines of STAKES and the 
National Institute for Health and Welfare were followed. These good practices for 
register-based research include ensuring the anonymity of the data and guaranteeing 
safekeeping of the data. (Martikainen, 2008) The study protocol for each of the sub-
studies was approved by the Research Ethics Committees of STAKES or the 
National Institute for Health and Welfare.  
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5 Results  
This study focused on changes in medical practice over time in medication use (I, II) 
and surgical operations (III, IV) to prevent and treat coronary complications among 
persons with diabetes. 
 
5.1 Trends in medication  
5.1.1 Secondary preventive medication for CHD (sub-study I) 
 
The first study compared secondary preventive medication for coronary heart 
disease between CHD patients with or without diabetes. Since CHD is a chronic 
disease, the study focused on those with newly diagnosed coronary heart disease to 
guarantee similar drug prescribing practices between the two patient groups. Trends 
in filled prescriptions for CHD medication among persons with newly diagnosed 
coronary heart disease with and without diabetes were examined in an unselected 
population; in other words, the population covers hospitalised patients and those 
who received their diagnosis in primary health care or occupational health care (I). 
Trends were examined in lipid-lowering medication, beta blockers, ACE inhibitors 
and Angiotensin II receptor antagonists in 1997–2002. The medications to treat and 
prevent coronary complications include both older and newer drugs. The lipid-
lowering medication mainly comprised statins, which were introduced for the 
treatment of CHD in the 1990s (Strandberg et al., 1997). To examine potential 
differences in the use of medication, the results were reported by socioeconomic 
group. 
 
At the beginning of study period, 88% of diabetes patients used beta blockers; 
among patients without diabetes the percentage was 89%. ACE inhibitors were used 
by 48% of diabetes patients compared to 25% of persons without diabetes, and 
angiotensin II receptor antagonist use was rare – 2% of patients with diabetes and 
6% of those with CHD only. At the end of study period, beta blockers were used by 
93% of patients with diabetes and 90% of those without diabetes, the numbers for 
ACE inhibitors being 61% and 37%, and for angiotensin II receptor antagonists 18% 
and 11%, respectively. 
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The patterns of medication use among newly diagnosed CHD patients changed 
during the study period, the use of RAAS inhibitors increasing especially among 
patients with diabetes, in line with treatment guidelines. Beta blockers presented a 
constant pattern of high use (over 85%) throughout the study period (1997–2002); 
the use of this old drug seemed to have reached a saturation point before the study 
period, and use remained high in all patient groups during the whole study period. 
 
In lipid-lowering medication use, an increasing trend was found among persons both 
with and without diabetes. The number of cases of lipid-lowering medication use for 
men with diabetes varied from 41% to 79%, being 55%–82% for men without 
diabetes. For women with diabetes, use of lipid-lowering medication was 39% in the 
beginning and 83% at the end of the study period, being 45%–77% for women 
without diabetes. Despite the increase, medication use remained at a lower level 
among men with CHD and diabetes compared to those with CHD only (Risk ratio 
0.94; 95% CI 0.90–0.98). When investigating socioeconomic differences among all 
CHD patients, differences were found in lipid-lowering medication use at the 
beginning of the study period, suggesting underuse of statins among lower 
socioeconomic groups among both men and women. However, lipid-lowering 
medication use increased throughout the study period, and after a health insurance 
reform in 2000, the socioeconomic differences in medication use disappeared.  
 
5.1.2 Lipid-lowering medication (sub-study II) 
 
The second study described lipid-lowering medication use among patients with 
newly diagnosed diabetes, taking into account sociodemographic factors and 
comorbidities. The study (II) also examined the impact of diabetes diagnosis on the 
use of lipid-lowering medication. This medical practice was described before and 
after compulsory generic substitution of pharmaceuticals and decreasing prices of 
lipid-lowering medication. 
 
The study population included annual cohorts of persons with a new diagnosis of 
diabetes in 2000–2006. In the first study year, 18% of men with diabetes only were 
on lipid-lowering medication, the percentages being 52% among men with CHD 
diagnosed before diabetes and 59% among men with coincident diagnosis of CHD 
and diabetes. In the last study year, the percentages were 38%, 79% and 80%, 
respectively. In the 2000 cohort, among women 20% of those with diabetes only 
were on lipid-lowering medication, the percentages being 48% among women with 
CHD diagnosed before diabetes and 57% among women with coincident diagnosis 
of CHD and diabetes. In 2006, the percentages were 40%, 73% and 75%, 
respectively. Hence, a trend of increasing lipid-lowering medication use was 
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detected among both men and women. The use of lipid-lowering medication before 
diabetes diagnosis was modest among persons without CHD compared to new 
diabetes patients with CHD, as expected. At the time of increasing use of lipid-
lowering medication, an independent effect of the diagnosis of diabetes on 
medication use was found. The effect remained throughout the study period, being 
the largest among patients with coincident diagnosis of diabetes and CHD. 
 
Focusing on changes in lipid-lowering medication use among all new diabetes 
patients by socioeconomic group, a growing trend was found in all income quintiles. 
Among the lowest income quintile, the percentage of medication was 20% in 2000 
and it was nearly 40% by 2006. There was fluctuation in the ranking of the other 
income quintiles in different years, but all other quintiles were almost 10% higher 
than the lowest one throughout the study period. 
 
To summarise, the results indicate that evidence-based drug use for CHD has 
increased. The use of new drugs to prevent and treat coronary complications (RAAS 
inhibitors) has increased and is higher among persons with diabetes compared to 
those with CHD only. From the equity perspective, socioeconomic differences in 
lipid-lowering medication use among CHD patients have, in general, diminished. 
However, the use of lipid-lowering medication was lower in the lowest income 
group compared with the others in the incident diabetes population. Among the 
diabetes population, the indication for prescription of lipid-lowering medication 
seems mainly to be CHD; characteristically in the 2006 cohort, the percentage of 
lipid-lowering medication use was almost 40% among persons with diabetes only 
but nearly twice as high among persons with CHD. 
 
5.2 Trends in coronary revascularisations 
5.2.1 Access to revascularisation (sub-study III) 
 
The third study focused on examining how diabetes modified access to the first 
coronary revascularisation among a cohort of coronary patients with and without 
diabetes and socioeconomic differences in access to these operations. The study 
question was examined in the context of increasing resources being invested in 
coronary revascularisations during the study years.  Specific health technology used 
in coronary revascularisation was analysed by separately examining CABG and PCI, 
where CABG represents an invasive technology that has been in use longer and PCI 
a newer invasive technology. The decision on what the best choice is for specific 
patients depends on clinical factors.  
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During the study period (1995–2002), resources for coronary revascularisation 
increased rapidly (III). Among men with CHD, the likelihood of revascularisation 
was lower among those with diabetes especially towards the end of the study period. 
Among men without diabetes, the revascularisation rate increased from 354 (95% CI 
341–367) in 1995 to 443 (95% CI 428–458) per 1000 person-years in 2002; among 
men with diabetes, the rate also increased but less rapidly, from 301 (95% CI 258–
344) to 366 (95% CI 363–435). Among women with CHD, the rates were similar 
level at the beginning of the study period regardless of diabetes status, but the 
presence of a diabetes diagnosis seemed to increase the likelihood of coronary 
revascularisation compared to those without diabetes towards the end of the study 
period. The revascularisation rate among women without diabetes was 224 (95% CI 
204–245) in 1995 and 249 (95% CI 227–272) by 2002, simultaneously among 
women with diabetes, the rate increased from 208 (95% CI 151–265) to 325 (95% 
CI 255–395). 
 
The majority of first coronary revascularisations was performed using CABG in the 
mid-1990s in all patient groups. For persons without diabetes, the use of PCI 
increased in the early 2000s, while among men with diabetes CABG remained the 
more common of the two procedures. Among women with diabetes, CABG and PCI 
were used equally often. When examining the diabetes population by diabetes type, 
the likelihood for using CABG at the first coronary revascularisation was elevated 
among women with type 1 diabetes and among men and women with type 2 diabetes 
in the early 2000s. The biggest patient group was men with CHD, and therefore PCI 
was the most used health technology in first coronary revascularisation in the early 
2000s. 
 
The trend in socioeconomic equity in access to these operations by diabetes status 
was also analysed (III). Among men with CHD both with and without diabetes, a 
socioeconomic gradient in the use of coronary revascularisation was observed 
throughout the study period: the lower the income group, the lower the likelihood. 
The pattern was less consistent among women, in particular among women with 
both diseases. Despite the increase of resources allocated to coronary 
revascularisations, a socioeconomic gradient persisted in access to revascularisations 
regardless of diabetes status. 
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5.2.2 Pathways to revascularisation (sub-study IV) 
 
During the study period (1998–2007), medical practices changed to favour coronary 
revascularisation in the first treatment period for CHD, whereas the pathways to the 
operation have been reported to have been more varied earlier among persons 
undergoing revascularisation. The fourth study examined hospital treatment 
pathways leading to the first coronary revascularisation and compared pathways to 
the treatment among patients with and without diabetes in yearly cohorts in the 
period 1998–2007 (IV). While the numbers of procedures performed in the first 
treatment period increased rapidly among men regardless of diabetes status, the 
numbers remained lower among men with diabetes, especially insulin-dependent 
diabetes, throughout the study period. Among men without diabetes, the increase 
was from 28% of operations being performed in the first treatment period in the 
beginning of the study period to 77% towards the end of the period. Among men 
with insulin-dependent diabetes, the numbers of coronary revascularisation 
performed in the first treatment period were 16% and 58%, and among those with 
non-insulin dependent diabetes 25% and 69%. When modelling the odds for 
undergoing revascularisation during the first hospital admission at the beginning and 
the end of the study period (1998–2000; 2005–2007), even after controlling for 
comorbidities the probability was low (0.73; 95% CI 0.54–0.99) at the beginning 
and remained low (0.52; 95% CI 0.42–0.64) at the end of the study period among 
those with insulin-dependent diabetes compared to men without diabetes, and the 
odds for men with non-insulin dependent diabetes was also low (0.86; 95% CI 0.77–
0.96 and 0.79; 95% CI 0.73–0.86) compared to men without diabetes.  
 
For those with CHD only, the figures were 32% at the beginning and 77% at the end 
of the study period; for women with insulin-dependent diabetes, the figures were 
36% and 64%, whereas among women with non-insulin dependent diabetes, the 
figure increased from 33% to 73%. Among women with diabetes, the odds for 
undergoing revascularisation in the first hospital admission was similar to that 
among men. For women with insulin-dependent diabetes, the odds were 0.76 (95% 
CI 0.52–1.11) at the beginning and 0.59 (95% CI 0.44–0.78) at the end of the study 
period compared to women without diabetes even after controlling for comorbidities. 
For women with non-insulin dependent diabetes, the corresponding figures were 
0.95 (95% CI 0.83–1.10) and 0.83 (95% CI 0.74–0.93). 
 
The study also examined trends in suboptimal treatment pathways to 
revascularisation among persons with and without diabetes (IV). Suboptimal 
treatment pathways were defined as including more than one cardiac emergency 
hospitalisation during two years preceding first revascularisation. While fewer 
operations were performed during the first CHD hospitalisation among patients with 
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diabetes, they also showed a higher probability of suboptimal treatment pathways to 
revascularisation throughout the study period. Among men with insulin-dependent 
diabetes, the odds for a suboptimal treatment pathway was elevated [1.67 (95% CI 
1.26–2.22) in 1998–2000 and 1.95 (95% CI 1.38–2.76) in 2005–2007] even after 
controlling for comorbidities. For men with non-insulin dependent diabetes, the odds 
were similar to those among men without diabetes [1.12 (95% CI 1.00–1.26) and 
1.12 (95% CI 0.96–1.30)] in both periods. For women with insulin-dependent 
diabetes, the figures were 1.52 (95% CI 1.00–2.30) and 1.91 (95% CI 1.22–3.00) 
after controlling for comorbidities, and for women with non-insulin dependent 
diabetes, the figures were 1.28 (95% CI 1.10–1.49) and 1.30 (95% CI 1.22–3.00). 
 
Similarly to drug use, an increasing trend in the use of coronary revascularisations 
was found. A rapid increase of resources increased the number of coronary 
revascularisations by some 25% in Finland between 1997 and 2002. At that time and 
consistently afterwards (1998–2007), medical practices have changed so that the use 
of CABG has decreased while PCI has increased. Despite this, CABG was the more 
common procedure among patients with diabetes throughout the study period. In 
pathways leading to coronary revascularisation, patients with diabetes had an 
elevated risk of delays to their operation, and the pathways might contain several 
cardiac emergency hospitalisations. 
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6 Discussion  
The overall purpose of this study was to examine changes in medical practices over 
time using register-based data. More specifically, the study examined changes in 
medical practices in CHD treatment among persons with diabetes. Two types of 
medical practices were examined, namely medication use and surgical operations to 
prevent and treat CHD. The results are based on longitudinal data, and the time 
window in each sub-study was long enough to observe changes in medical practices. 
While no empirical data are available concerning the direct influence of external 
factors influencing the results, the results are discussed in the context of these 
changes. These Finnish factors include at least increasing resources in coronary 
revascularisations, decreasing prices of lipid-lowering medication, restricted 
reimbursement on the use of statins, programme for treatment of diabetes and 
preventing CHD among persons with diabetes (DEHKO), and production of 
nationwide clinical guidelines.  
 
The choice of patient group was motivated by the fact that earlier studies in Finland 
and elsewhere on medical practices in CHD treatment among patients with diabetes 
have raised concerns about undertreatment (Alter et al., 2003; Gitt et al., 2003; 
Norhammar et al., 2003; Hetemaa et al., 2006; Salomaa et al., 2007). Earlier studies 
have also reported socioeconomic differences in access to coronary 
revascularisations among CHD patients with and without diabetes (Hetemaa et al., 
2003; Hetemaa et al., 2004; Hetemaa et al., 2006; Manderbacka et al., 2009). The 
objectives originated from the lack of studies on health technology change adopted 
in medical practices and focusing on patient groups with multimorbidity, i.e. patients 
with two chronic diseases – CHD and diabetes – and in different socioeconomic 
groups. (McClellan & Kessler, 2002) 
 
The results showed that good treatment practices to prevent vascular complications 
among persons with diabetes have become more widespread. Methodologically, the 
used risk-adjustment methods designed specifically for Finnish register-based data 
ensured justified comparisons between groups and between different time periods. 
Despite the increase of good treatment practices, the results raise some concerns of 
undertreatment among patients in a low socioeconomic position and with newly 
diagnosed diabetes and regarding the managing of treatment pathways to coronary 
revascularisation among patients with diabetes. This information can be used to 
develop targeted interventions in CHD treatment aimed at taking special needs of 
persons with diabetes into consideration.  
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6.1 Overview of the main results  
6.1.1 Use of CHD medication  
 
At the population level, guidelines advise the including of RAAS inhibitors in 
secondary preventive medication for CHD for hypertensive patients, and lipid-
lowering medication is assumed to be a necessity for majority of CHD patients 
(Ryden et al., 2007; ESC 2013). Trends of increasing medication use for CHD were 
found among persons with and without diabetes between 1997 and 2002. These 
findings of growing trends were similar to findings of hospitalised CHD patient 
samples in Finland and other European countries (Kotseva et al., 2009; Nichols et al., 
2012), but these results did not provide subgroup analysis for patients with CHD and 
diabetes. Comparisons between countries emphasise the fact that prescribing 
patterns vary: beta blocker use was highest in Finland among hospitalised CHD 
population, while ACE inhibitor use remained lower compared to the Netherlands 
and Germany. (Kotseva et al., 2009; Nichols et al., 2012) 
 
The findings of the differences in medication use between CHD patients with and 
without diabetes showed that the use of RAAS inhibitors was more common among 
patients with diabetes and CHD, in line with the recommendations of treatment of 
hypertension among persons with diabetes. The finding that no socioeconomic 
differences were detected in the use of beta blockers corroborates previous findings 
among hospitalised MI patients and a sample of prevalent CHD patients in Finland 
(Salomaa et al., 2001; Salomaa et al., 2007; Manderbacka et al., 2008), whereas 
some international studies have reported socioeconomic differences in anti-
hypertensive medication use in the general population (Corrao et al., 2008; 
Friedman et al., 2010). In addition, a dissemination study among persons with 
hypertension reported no systematic differences by socioeconomic status in how 
rapidly this population adopted new anti-hypertensive medications (ACE inhibitors) 
(Goldman & Smith, 2005). In terms of subsequent development in Finland, in the 
last study year (2002) the use of RAAS inhibitors still seemed to have room for 
growth, while the use of older medication, beta blockers, seemed to have peaked 
among all newly diagnosed CHD patients. 
 
In Western countries, the use of lipid-lowering medication has increased in the 
general population since the mid-1990s, as described earlier for Finnish elderly 
people, hospitalised CHD patients, and hospitalised AMI patients (Walley et al., 
2005; Salomaa et al., 2007; Kotseva et al., 2009; Ruokoniemi et al., 2011; Nichols et 
al., 2012). In light of these studies, the increase in the use of lipid-lowering 
medication in an unselected CHD population with diabetes was not unexpected. In 
2000, the level of lipid-lowering medication use in the Finnish population was 
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around the European average, and variation of prescribing patterns was reported 
both in the general population and in the hospitalised CHD population (Walley et al., 
2005; Kotseva et al., 2009; Nichols et al., 2012). Similarly to these Finnish results, 
the use of lipid-lowering medication increased in the whole population and in the 
hospitalised CHD population (Walley et al., 2005; Kotseva et al., 2009), and the 
results suggest room for growth in this use among CHD patients both with and 
without diabetes at the turn of the millennium. 
 
Earlier studies on lipid-lowering medication use reported socioeconomic gradients 
in the hospitalised AMI population in Canada (Austin et al., 2006; Selmer et al., 
2009) and among patients with diabetes in Norway (Selmer et al., 2009) and 
Denmark (Thomsen et al., 2005). In the patient group comparisons, the lower use of 
medication found among CHD patients with diabetes raised concerns of 
undertreatment. (Brown et al., 2004; Mantel-Teeuwisse et al., 2004; Simpson et al., 
2005; Ward et al., 2005; Salomaa et al., 2007; Selmer et al., 2009; Neutel et al., 
2010; Ohlsson et al., 2010; Eliasson et al., 2011) Findings from this longitudinal 
study design revealed lower use among lower socioeconomic groups before 2000, 
but the socioeconomic differences disappeared thereafter. The criteria for the 
elevated reimbursement for lipid-lowering medication costs were widened to cover 
patients with CHD in 2000, and it is plausible that this reform, for its part, increased 
the use of lipid-lowering medication among CHD patients both with and without 
diabetes and thereby helped to abolish socioeconomic differences.   
 
According to the findings of this study, increasing use of lipid-lowering medication 
was detected among persons with a new diabetes diagnosis in 2000−2006. However, 
differences were detected by CHD status: the percentage of users was lowest among 
persons with diabetes only. Additionally, while a growing trend of lipid-lowering 
medication was found in all socioeconomic groups, there were consistent differences 
in the level of use. An increase in lipid-lowering medication use has also been 
reported in diabetes populations in other Nordic countries (Fhärm et al., 2008; 
Dominguez et al., 2009; Gudbjornsdottir et al., 2009), the UK, Irland, Germany, 
Canda, the USA, and Australia (Teeling et al., 2005; Wan et al., 2006; Soljak et al., 
2007; Raum et al., 2008; Segars & Lea, 2008; Berthold et al., 2009; Neutel et al., 
2010). There are inbuilt differences in the inclusion criteria for diabetes as well as 
CHD-related comorbidities between the studies, and therefore straightforward 
comparisons between them are problematic, but comparing the latest studies with 
the earlier ones it seems that the earlier reported a lower level in lipid-lowering 
medication use. There are also likely to be differences in prescription patterns for 
lipid-lowering medication between countries. 
 
Few if any studies have estimated the impact of diabetes diagnosis to the initial use 
of lipid-lowering medication using longitudinal study design and register-based data. 
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Because the diagnosis of diabetes implies a contact with health care and because the 
data allowed looking at lipid-lowering medication before and after diabetes 
diagnosis, this question was addressed. At the time of increasing use of lipid-
lowering medication, an independent effect of diabetes diagnosis on medication was 
found: the diagnosis increased usage in all patient groups. The effect was largest 
among those with coincident diagnosis of CHD, suggesting that CHD remains the 
main indication for lipid-lowering medication. Furthermore, lipid-lowering 
medication use was lower in the lowest socioeconomic group among patients with 
diabetes only. This may partly have been due to differences in the reimbursement of 
medicine costs between persons with diabetes compared to those with CHD. In 
Finland, prices for lipid-lowering medication decreased continuously from the mid-
1990s, and following obligatory generic substitution for pharmacy in 2003 all 
patients could choose a cheaper generic alternative. In 2006, some statins were 
relatively cheap, but the cost of medication might still have constituted a threshold 
for medication use for some patient groups (Doshi et al., 2009; Martikainen et al., 
2010). Similar results concerning lesser use of these drugs in the lowest 
socioeconomic group have been reported in the Danish diabetes population 
(Dominguez et al., 2009). International guidelines and guidelines in both countries 
recommended the use of lipid-lowering medication for patients with diabetes 
(Haffner & American Diabetes Association, 2004; Snow et al., 2004; Suomen 
Sisätautilääkärien Yhdistys ry:n asettama työryhmä, 2004; Dominguez et al., 2009; 
Suomalaisen Lääkäriseuran Duodecimin, Suomen Sisätautilääkäreiden yhdistyksen 
ja Diabetesliiton Lääkärineuvoston asettama työryhmä, 2012). Discussion on 
prescribing patterns, patients’ adherence to medication use and the impact of 
guidelines to change in medical practices would be helpful for increasing overall 
understanding of the observed differences. (Roine et al., 2003; Fhärm et al., 2008; 
Raum et al., 2008; Toth et al., 2009) 
 
These changes in medication took place during years when the number of new 
diabetes cases increased, which was partly related to an epidemic of overweight and 
the increasing age of the population, and partly to awareness of the early signs of 
diabetes. One of the DEHKO programme targets was to advance the timing of the 
diagnosis. Unfortunately, the empirical study data do not cover the last years of the 
DEHKO nor the years thereafter, and thus the recent changes in the use of 
medication among patients with diabetes remain unclear. 
 
6.1.2 Coronary revascularisations 
 
One of the objectives of this nationwide register-based study was to examine 
whether the diagnosis of diabetes modifies access to coronary revascularisation. At 
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the time of increasing resources in coronary revascularisations, medical practices in 
coronary revascularisation to treat already existing CHD have changed. The use of 
PCI increased substantially, but CABG remained the more common of the two 
procedures among patients with CHD and diabetes. Among men with diabetes, 
access to the coronary operation was lower compared to those without diabetes 
despite the evidence suggesting that patients with a high-risk profile benefit from 
coronary revascularisation the most, while the gain among low-risk patients is 
smaller (Yusuf et al., 1994; Lagerqvist et al., 2005). The result is in line with earlier 
hospital-based studies in Sweden, Germany and Canada (Alter et al., 2003; 
Norhammar et al., 2003; Otter et al., 2004). The study design was wider than that of 
earlier studies examining changes in medical practice over time that focused on AMI 
patients and yields more information concerning a high-risk group (i.e. patients with 
diabetes) (McClellan & Kessler, 2002). Earlier research reported socioeconomic 
differences in revascularisation in the CHD population in Finland, Sweden, the UK 
and Canada in the early 1990s (Keskimäki et al., 1997; Alter et al., 1999; Haglund et 
al., 2004; Morris et al., 2005; Hetemaa et al., 2006). 
 
In the current study, a socioeconomic gradient in access to the operations was found 
among men in both patient groups: the higher the socioeconomic group, the higher 
the probability of coronary revascularisation. Among women with diabetes, the 
increase in coronary revascularisation rates seems to have improved equity in access 
to operation. The finding of a socioeconomic gradient among men corresponded 
with international findings (Haglund et al., 2004; Morris et al., 2005).   
 
During the study period 1998−2007, medical practice concerning the timing of the 
operation also changed: it became more and more common to perform coronary 
revascularisation already during the first hospital admission. The results showed that 
suboptimal pathways including several emergency admissions before access to first 
coronary revascularisations remain more common among patients with diabetes. It is 
likely that CABG will more often be planned for a subsequent hospitalisation than 
PCI and may need more preparatory investigations. However, longer pathways to 
treatment seem to increase the risk for unscheduled emergency admissions among 
persons with diabetes, suggesting inability to take into account the needs of these 
high-risk patients. Nevertheless, the incidence of suboptimal pathways decreased in 
all patient groups during the study period.   
 
Comparison possibilities to other studies with this study design using individual-
level pathways with a retrospective perspective are scarce. A cohort study of MI 
admissions in hospitals in California reported both ethnic and payer-group 
differences in the treatment pathways. Minority patients and uninsured patients were 
less likely to have treatment pathways leading to revascularisation (Blustein et al., 
1995).  
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To conclude, medical practices have changed in two ways during the study period: 
PCI use increased and CABG use decreased between 1995 and 2007. Among 
patients with diabetes, CABG was more common throughout the study period, 
which is also suggested by the evidence that has slowly accumulated. Persons with 
diabetes have an elevated risk of delays to operation, and the pathways may contain 
several cardiac emergency hospitalisations. A significant and well-prepared extra 
investment in coronary artery disease operations and new technology used in PCI 
enabled spreading good pathways.  
 
During the study period and thereafter, resources to perform coronary 
revascularisations have increased considerably. Firstly, the number of cardiologists 
of working age increased year on year from 74 up to 225 between 1997 and 2012 
(i.e. the growth percentage was 204%). Secondly, the number of coronary 
revascularisations increased by 90%, from 5 714 in 1997 to 10 835 in 2011. This 
increase happened in 1997–2002; after 2003 the numbers stabilised and have stayed 
at almost the same level since.  
 
There may have been professional uncertainty in the choice of invasive treatment 
between PCI and CABG for patients with diabetes. The best treatment option of 
coronary revascularisation for patients with diabetes has been a subject of discussion 
for a long time (Grundy et al., 1999; Niles et al., 2001; Flaherty & Davidson, 2005; 
Ryden et al., 2007; Aronson & Edelman, 2010). The bypass Angioplasty 
Revascularisation Investigation trial suggests that CABG has better long-term 
treatment outcomes among patients with diabetes at the time of 10-year follow up 
(The BARI Investigators, 2007). 
 
6.2 Methodological considerations  
 
This national level register-based study used administrative registers with individual 
linkages and examined changes in medical practices in a time window long enough 
for observing changes. It also provided information about treatment trends within 
socioeconomic groups. The present results are significant in at least four respects: 
firstly, the selection of patient groups was tailored for a longitudinal register-based 
study; secondly, the analysis took into consideration different case-mixes enabling 
comparisons between patient groups; thirdly, the data enabled construction of 
treatment pathways at the individual level; and fourthly, the examination of medical 
practice change was carried out not only at the level of the health care system as a 
whole but also from an equality perspective. 
 
Discussion 
 
THL — Research 2014•131 59 Examining time trends in medical practices using register-based data  
 
The register-based data comprehensively cover all diagnosed and medically treated 
diabetes cases in Finland. The registers of special reimbursement as well as the 
prescriptions database are good sources for identifying people with diabetes. Since 
these registers are administrative and based on actual reimbursement of costs, the 
coverage is likely to be high. In addition, identification of people with diabetes was 
done by combining data from several administrative registers (Hospital Discharge 
Register, Benchmarking database). (Sund & Koski, 2009) However, these data do 
not include undiagnosed diabetes patients or persons with only dietary treatment for 
diabetes and without hospital discharges, only cases with a disease identified by 
physicians. These patient population data facilitated the providing of information 
about a real-world patient group using health care. Linking individual-level data on 
socioeconomic factors using unique personal identifiers prevented ecological bias 
(i.e. assigning individuals socioeconomic status using area-based aggregated level 
information on deprivation). Combining registers for study use provided already 
existing follow-up data. Compared with the typical samples of randomised clinical 
studies, the cases in the longitudinal register-based data gave better coverage of 
persons from all socioeconomic groups, persons with multimorbidity and women. 
(Bartlett et al., 2005)   
 
A review of the validity of the Hospital Discharge Register in Finland has been 
carried out recently (Sund, 2012). At least 32 studies have documented the 
Register’s validity, focusing on certain diseases in certain time periods. Validity 
research of vascular disease, mental disorders or injuries showed to be the most 
common among studies comparing the Hospital Discharge Register data to external 
information. The coverage of the Hospital Discharge Register was found to be good, 
and more than 95% of discharges could be identified, however, the poor recording 
of subsidiary diagnoses and secondary operations found in the review limits the 
Hospital Discharge Register’s validity. Sensitivity and positive predictive value are 
used in validity research besides the coverage, and the results for the Hospital 
Discharge Register varied depending on the condition and years. Sensitivity can, in 
other words, be considered as a true-positive rate, and the positive predictive value 
indicates the proportion of register-detected cases that were confirmed to be true-
positives according to some external data (Sund, 2012). For example, a study 
assessing the validity of Hospital Discharge Register using external information 
from the FINAMI register in 1988–2002 found the sensitivity for myocardial 
infarctions to be 82% and the positive predictive value to be 90%. (Pajunen et al. 
2005)  
 
Administrative medical databases are massive repositories of data, but they are not 
primarily collected for research purposes. In Finland, such databases are maintained 
by the THL and SII, but data collection takes place in various places (hospitals, 
health care centers, and pharmacies). The legislation (Finlex 556/1989; 774/1989 
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and 668/2008) assigns a responsibility to health care providers to provide 
information to the competent authorities keeping these registers (THL, before 2009 
Stakes), including information on coronary revascularisation operations. Regarding 
hospital discharge data, generally identified problems include questions on the 
usability of the data entry, concerns about the coverage of the data and delays to the 
completion of the data. (Räsänen 2013) The coverage of Hospital Discharge 
Register data regarding the additional information page for CHD patients has 
recently been criticised. Furthermore, a need for the follow-up of treatment 
outcomes and complications has been voiced. (Laine, 2013; Mustonen, 2012) In the 
early 1990s, a study documented problems in the reporting of coronary 
revascularisation procedures (Hetemaa et al. 2003). In the absence of a gold standard, 
the hospital discharge data concerning numbers of performed coronary 
revascularisations can be compared to two separate datasets: the Finnish Heart 
Association collected aggregated data on coronary revascularisation procedures 
from the mid-1990s up to 2005, and the Finnish Cardiac Society has published 
annual surveys since 2007 reporting numbers of invasive cardiac procedures at 
university and central hospitals (Finnish Heart Association, 2006; Mustonen J et al. 
2013). Comparing numbers of coronary revascularisations between THL registers 
and the Finnish Heart Association in 2000, the THL register reported more CAGBs 
(n=4 703 vs. 4 113, 114%) and fewer PCIs (n=3 648 vs. 3 930, 93%) than the 
Finnish Heart Association. In 2010, a comparison between THL registers and the 
Finnish Cardiac Society data found that the THL register had more CAGBs 
(n=2 587 vs. 2 110, 123%) and fewer PCIs (n=7 970 vs. 8 968, 89%). (Finnish Heart 
Association, 2006; Mustonen J et al. 2013; THL, 2013)  
 
The coronary revascularisations examined in this study are cases found in the 
hospital discharge data, the additional information page of CHD patients or the 
benchmarking register. However, there is no reason to expect that the distribution of 
the procedures missed in the data used is other than random in the different 
population groups examined in the present study. It is unlikely that the basic trend 
would change substantially if some PCIs are missed. The effect of potential regional 
variation in the reporting of revascularisations to the registers cannot be estimated 
due to lack of data for comparisons.  
 
Linking the Hospital Discharge Register data with several other registers in order to 
build comprehensive research databases is suitable for addressing research questions 
in health services research. However, additional cross-matching of registers or 
specific validation studies are needed in the future, and therefore efforts for cross-
matching registers for validation purposes should be made. Nonetheless, 
administrative databases can be used as a robust research tool to examine a variety 
of clinical and demographic themes (Gavrielov-Yusim & Friger, 2014). 
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Despite the strengths of the data, there are limitations that need to be considered 
when evaluating the results. Firstly, the register-based data do not cover patients 
with diabetes treated only with diet. However, recent recommendations tend not to 
prefer long-term diet try-outs, and instead advise the starting of oral diabetes 
medication. (Suomalaisen Lääkäriseuran Duodecimin, Suomen Sisätautilääkäreiden 
yhdistyksen ja Diabetesliiton Lääkärineuvoston asettama työryhmä, 2012; Laakso, 
2013) Secondly, with regard to the CHD cases, the definition does not cover those 
with mild symptoms of CHD, and medicated only with inexpensive nitroglycerin, 
still the used definitions of diagnosed CHD extended the cases from hospital 
populations, which have mainly focused on MI. Thirdly, management of diabetes 
and CHD has strong behavioural components which can increase or decrease the 
risk of CHD and its complications. Unfortunately, information on behavioural 
components or clinical data is not provided by registers in Finland, and this should 
therefore be investigated in separate sample studies. Fourthly, in terms of drug use, 
the data provide only indirect evidence on the potential effect on the level of drug 
use of reimbursement schemes or prescription practices or patient choice of whether 
to purchase the drugs with a higher price. Taking these limitations into account, the 
results of this study, using administrative registers that collect unselected 
information on health care use and social status, provide a good information source 
for investigating changes in medical practice over time.  
 
The methods used in the sub-studies have a number of attractive features: Firstly, a 
different case-mix between patient groups could be adjusted for in the statistical 
analysis using common methods for register-based studies (I, III) or tailored 
adjustment for Finnish register-based data (II, IV). Taking into account differential 
comorbidity between the patient groups strengthens the conclusions concerning 
differences between patient groups. Secondly, broad individual-level data and 
methods were used to examine the effect of sociodemographic determinants through 
the study period. Thirdly, specific time periods were modelled comparing different 
time points between patient groups, which enables taking into account changes in 
patient populations in terms of disease incidence or age at the onset of disease (II, 
IV). Fourthly, novel study designs were developed to address the study questions 
from new perspectives: yearly cohorts of new diabetes cases before and after onset 
of the disease allowed examination of risk-adjusted changes in medication use (II), 
and a retrospective follow-up enabled focusing on care pathways (IV). Compared to 
other studies, these qualities make Finnish register-based datasets dependable 
information sources for studying medical practices. The potential for longitudinal 
studies provide opportunities to examine changes in these practices.  
 
Finnish register data allow exceptionally comprehensive longitudinal follow-up of 
individuals, as deterministic record linkages within and between registers using 
personal identity code can be made. The use of nationwide and individual-level 
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register-based data and methods with case-mix control provide advantages in 
comparing subgroups and different time periods; previous studies on medical 
practices have not always combined these elements concurrently. Besides 
nationwide administrative registers, certain other types of register have been used to 
examine medical practices, namely research, quality and benchmark registers. Many 
of these are regional, or based on one organisation, limited to a sample. Unlike 
administrative registers, many of them are voluntary. In summary of the methods 
used in the reviewed register-based studies examining changes in medical practice 
over time, the comparisons between groups have often used just crude numbers and 
proportions, and only some studies have used specific case-mix corrections. 
Nevertheless, the description of medical practice using crude numbers and 
proportions is an important first step in identifying problems and challenges in 
health care (Munk-Jorgensen et al., 1992; Robertsson et al., 2000; Pijl & Sytema, 
2003; Arvidsson & Ericson, 2005; Fonarow et al., 2007; Priftis et al., 2007; Gibson 
et al., 2008; Gualano et al., 2010; Ravera et al., 2010). However, if the focus is on 
comparison of sub-groups, the different case-mix needs to be taken into account, and 
some international studies have had the  ability for this (Zahn et al., 2000; Marques-
Vidal et al., 2003; Lay et al., 2007; Moist et al., 2008; Nguyen et al., 2010; Chin et 
al., 2011; Kuklina et al., 2011). If the relevant individual-based data are available, 
methods similar to those employed in this dissertation can be used in other health 
care settings, provided that the numbers of cases in smaller areas (regions, 
organisations) are not too small. Describing changes in medical practice over time 
provides a tool for understanding health care. 
 
6.3 Conclusions  
 
Investigated changes in CHD treatment over time among patients with diabetes 
and/or CHD indicate that, in general, recommended treatment practices have 
become more common. These changes in treatment practices took place at a time 
when resources for coronary revascularisations increased, new pharmaceutical 
treatments were introduced, special reimbursement rights for lipid-lowering 
medication costs were extended to patients with CHD and generic substitution was 
launched. Moreover, a programme for prevention and treatment of diabetes and its 
cardiovascular comorbidities was in operation, and Current Care guidelines were 
produced. However, the data of this study do not provide direct evidence on whether 
policy interventions actually led in the direction intended.  
 
This non-experimental method of examining changes in medical practice over time 
in different patient groups proved to be useful for describing the level and 
distribution of the treatment overall and in different patient populations. Using 
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individual-level register-based data and proper risk adjustment methods enables the 
elimination of individual-level variation and the comparing of different patient 
groups. Examining variations in medical practice over time using nationwide health 
care registers can be useful for evaluating changes in society and health policy 
actions concurrently. Overall, the present study can facilitate the interpretation and 
understanding the results of empirical studies on changes in medical practice over 
time. 
 
6.4 Challenges for future research 
 
The findings of this study suggest that good treatment practices to prevent CHD and 
its complications among persons with diabetes have increased concurrently with 
increasing resources for coronary revascularisations and a framework focusing on 
diabetes care, introduction of treatment guidelines and higher reimbursement for 
lipid-lowering medication costs extended to patients with CHD. After the study 
period, the Current Care guidelines including diabetes care have been updated and 
changes for reimbursement levels for CHD medication are planned. There is an 
apparent need for future studies using a similar non-experimental setting. One area 
where future studies are needed is changes in medical practice to prevent CHD 
complications. The results of the current study indicate that evidence-based 
medication use, i.e. new medication to control adverse events of CHD, has increased, 
but it is likely that it still remains at a suboptimal level, and further study is needed 
to find out whether the trend has continued up to the present. Future studies might 
also assess whether older medication (beta blockers) have been replaced partly by 
newer ones (RAAS inhibitors) or whether their use remains constantly at a high 
level as suggested by this study. Lipid-lowering medication use increased 
concurrently with widened indications for elevated reimbursement and with lower 
prices, and with obligatory generic substitution. However, the results suggest that 
socioeconomic differences in the use of lipid-lowering drugs still exist among the 
persons with a new diabetes diagnosis. Future studies are needed to investigate 
whether these differences in persons with incident diabetes will disappear. 
Additionally, further study should assess whether the use of lipid-lowering drugs 
remains at a high level among high income groups with CHD, or whether the 
growing concern about the association of lipid-lowering medication use with a small 
increase in the risk for diabetes or evidence or public preception of muscular pain 
due to drug use had an effect on the use of lipid-lowering medication (Rajpathak et 
al., 2009; Parker et al., 2013).  
 
Information about changing medical practices is important when determining the use 
of resources in health care. Different health technologies used in medical practice 
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demand different amounts of health care resources. In surgical operations, the overall 
tendency has been towards less invasive treatment, which requires less treatment days 
in the hospital. In conclusion, in the past at least there has been professional 
uncertainty in the invasive treatment of CHD patients with diabetes. The evidence of 
the best treatment for patients with CHD and diabetes has strengthened somewhat, 
and on-going adoption of new health technologies has challenged the best treatment 
choices (Aronson & Edelman, 2010). Register-based data offer possibilities to 
monitor the impact of drug price and reimbursement decisions in the use of 
medication, albeit indirectly. Medical practice needs to be studied using real-world 
data, and register-based studies offer a good opportunity for this.  
 
Concurrently with changes in health technology, factors such as health policy level 
regulation and resource allocation at a time of diminishing economic capacity 
associated with changes in medical practice will continue in the future. Special 
attention needs to be paid to important issues like the implementation of prevention 
and care of chronic conditions using relevant implementation tools including 
national strategies. Together with these changes in the macro level of health care, 
progress in factors at the meso level is likely to continue, e.g. updating of guidelines 
for evidence-based treatment and organising integrated care for chronic conditions. 
Future studies in the course of changes in medical practice at the level of the health 
care system – whether recommended practices will grow and undertreatment and 
poor practices become less common – are needed.    
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Appendix 1 
The search strategy of article selection and information extraction of the studies 
 
The studies for the literature review were retrieved from Medline, as it is the most 
comprehensive international bibliographic database within medicine, and also the 
database likely to contain the highest number of references relevant to the subject. 
Mesh Terms (Medical Subject Headings terms) used in the search included terms 
“Health Services” or “Delivery of Health Care”, and “Registers” or “Databases”, 
and “Trends”. Studies published in English between January 1946 and March 2012 
were accepted. (See detailed search strategy and flow diagram of article selection 
process on the next pages.)    
 
The search strategy yielded 297 titles and abstracts. Of these hits, 243 were excluded 
after examining the title and the abstract as secondary sources, including review 
articles, letters and commentaries. The whole text evaluation included 54 published 
articles, 24 of which were finally chosen to be included in the review (Figure 7). The 
criteria for including the articles for more detailed analysis were: firstly, that the data 
were register-based; secondly, that the outcomes of the study were related to 
medical practices and that the focus was related to health service use. If the article 
had several focuses such as efficiency or adverse effects of health care interventions, 
the evaluation took only health service use into account. The third criterion for entry 
was that the study design had to be longitudinal presenting temporal trends. 
 
The selected earlier studies (24) examining changes in medical practice over time 
using register-based data are presented in Table 2. Information extracted from the 
chosen studies included the first author, publication year, title of the study, medical 
practice(s), country of origin, and time period covered. Information on the study 
design included patient groups or other groups compared in the study, register(s) and 
methods used, case-mix correction, and results regarding medical practice in the 
study. In the earlier empirical studies, the methods used were classified into those 
focusing on descriptive and analytical approaches; and whether case-mix correction 
was used, in particular information of sociodemographic factors and comorbidity. 
Finally, the results were summarised to evaluate whether evidence-based or health 
policy reform driven medical practice was implemented and what kinds of trends 
emerged.   
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Literature search delivered 2.4.2012 
Database(s): Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and 
Ovid MEDLINE(R) 1946 to Present 
Search Strategy:  
# Searches Results 
1 exp *Health Services/ 781688 
2 exp *"Delivery of Health Care"/td [Trends] 15502 
3 exp *Public Health/td [Trends] 14047 
4 Epidemiology/td [Trends] 514 
5 ("health care" or "health service*" or "public health" or  "health status").ti. 124393 
6 or/1-5 892663 
7 exp *Registries/ 12360 
8 exp *Databases, Factual/ 19436 
9 (register or registers or registry or registries or administrative).ti. 17879 
10 or/7-9 42194 
11 6 and 10 4048 
12 (method* or trend* or develop* or chang* or histor* or theor*  or occurence or inciden* or prevalence or increas* or decreas*).ti. 1528746 
13 11 and 12 434 
14 exp Europe/ 997189 
15 exp United States/ 1012967 
16 exp Canada/ 107035 
17 or/14-16 2057211 
18 13 and 17 297 
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Figure 7. The flow diagram of article selection process 
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ed
en
 
19
87
–2
00
6 
N
at
io
na
l H
os
pi
ta
l 
D
is
ch
ar
ge
 R
eg
is
te
r, 
D
ea
th
 re
gi
st
er
 
(A
dm
in
is
tra
tiv
e 
re
gi
st
er
s)
  
D
es
cr
ip
tiv
e 
st
at
is
tic
s 
 
(n
um
be
rs
); 
in
ci
de
nc
e 
an
d 
st
an
da
rd
is
ed
 
m
or
ta
lit
y 
ra
te
s;
 
te
m
po
ra
l c
ha
ng
es
 
w
er
e 
te
st
ed
 b
y 
re
gr
es
si
on
 
A
dj
us
te
d 
by
 a
ge
  
Th
e 
pr
og
no
si
s 
of
 p
at
ie
nt
s 
w
ith
 
A
M
I i
m
pr
ov
ed
 a
nd
 th
e 
le
ng
th
 o
f 
st
ay
 in
 h
os
pi
ta
l d
ec
re
as
ed
. 
Th
es
e 
im
pr
ov
em
en
ts
 to
ok
 p
la
ce
 
si
m
ul
ta
ne
ou
sl
y 
w
ith
 th
e 
in
cr
ea
se
 
of
 h
os
pi
ta
lis
at
io
ns
 fo
r c
he
st
 
pa
in
, u
se
 o
f t
ro
po
ni
n 
m
ea
su
re
m
en
ts
 to
 d
ia
gn
os
e 
M
I, 
an
d 
us
e 
of
 e
vi
de
nc
e-
ba
se
d 
m
ed
ic
at
io
ns
 a
nd
 o
th
er
 
pr
oc
ed
ur
es
 fo
r t
he
 a
ng
in
a 
gr
ou
p.
  
A
pp
en
di
x 
2 
 
Ta
bl
e 
2.
 
R
ev
ie
w
 o
f t
he
 e
m
pi
ric
al
 s
tu
di
es
 e
xa
m
in
in
g 
ch
an
ge
s 
in
 m
ed
ic
al
 p
ra
ct
ic
e 
ov
er
 ti
m
e 
us
in
g 
re
gi
st
er
-b
as
ed
 d
at
a;
 d
es
cr
ip
tio
n 
of
 th
e 
st
ud
y,
 m
et
ho
ds
 u
se
d 
an
d 
m
ai
n 
re
su
lts
.  
??
?Fo
na
ro
w
 e
t a
l. 
(2
00
7)
:  
Te
m
po
ra
l t
re
nd
s 
in
 c
lin
ic
al
 
ch
ar
ac
te
ris
tic
s,
 
tr
ea
tm
en
ts
, a
nd
 o
ut
co
m
es
 
fo
r h
ea
rt
 fa
ilu
re
 
ho
sp
ita
liz
at
io
ns
, 2
00
2 
to
 
20
04
: f
in
di
ng
s 
fr
om
 A
cu
te
 
D
ec
om
pe
ns
at
ed
 H
ea
rt
 
Fa
ilu
re
 N
at
io
na
l R
eg
is
tr
y 
(A
D
H
ER
E)
. 
M
ed
ic
at
io
n 
du
rin
g 
he
ar
t 
fa
ilu
re
 
ho
sp
ita
liz
at
io
ns
 
Y
ea
rly
 c
oh
or
ts
 
U
S
A
 
20
02
–2
00
4 
B
en
ch
m
ar
k 
re
gi
st
ry
, 
A
cu
te
 
D
ec
om
pe
ns
at
ed
 H
ea
rt 
Fa
ilu
re
 N
at
io
na
l 
R
eg
is
try
 (A
D
H
E
R
E
) 
co
ve
rs
 2
85
 h
os
pi
ta
ls
  
D
es
cr
ip
tiv
e 
st
at
is
tic
s 
(n
um
be
rs
, 
pr
op
or
tio
ns
); 
 
te
m
po
ra
l c
ha
ng
es
 
w
er
e 
te
st
ed
  
N
o 
C
lin
ic
al
 c
ha
ra
ct
er
is
tic
s 
am
on
g 
pa
tie
nt
s 
w
ith
 h
os
pi
ta
lis
at
io
n 
du
e 
to
 h
ea
rt 
fa
ilu
re
 w
er
e 
re
la
tiv
el
y 
si
m
ila
r, 
bu
t i
nh
os
pi
ta
l m
or
bi
di
ty
 
an
d 
m
or
ta
lit
y 
im
pr
ov
ed
 
si
m
ul
ta
ne
ou
sl
y 
w
ith
 c
ha
ng
es
 in
 
in
tra
ve
no
us
 th
er
ap
y,
 in
cr
ea
se
 in
 
ev
id
en
ce
-b
as
ed
 m
ed
ic
at
io
ns
 
an
d 
en
ha
nc
em
en
ts
 in
 q
ua
lit
y-
of
-
ca
re
 m
ea
su
re
s.
  
G
ib
so
n 
et
 a
l. 
(2
00
8)
: 
Tr
en
ds
 in
 re
pe
rf
us
io
n 
st
ra
te
gi
es
, d
oo
r-
to
-n
ee
dl
e 
an
d 
do
or
-to
-b
al
lo
on
 ti
m
es
, 
an
d 
in
-h
os
pi
ta
l m
or
ta
lit
y 
am
on
g 
pa
tie
nt
s 
w
ith
 S
T-
se
gm
en
t e
le
va
tio
n 
m
yo
ca
rd
ia
l i
nf
ar
ct
io
n 
en
ro
lle
d 
in
 th
e 
N
at
io
na
l 
R
eg
is
tr
y 
of
 M
yo
ca
rd
ia
l 
In
fa
rc
tio
n 
fr
om
 1
99
0 
to
 
20
06
. 
R
ep
er
fu
si
on
 
th
er
ap
y 
in
 
m
yo
ca
rd
ia
l 
in
fa
rc
tio
n 
M
en
 a
nd
 w
om
en
;  
ag
e 
gr
ou
ps
; 
tra
ns
fe
r a
nd
 
no
nt
ra
ns
fe
r 
pa
tie
nt
s 
U
S
A
 
19
90
–2
00
6 
N
at
io
na
l R
eg
is
try
 o
f 
M
yo
ca
rd
ia
l I
nf
ar
ct
io
n 
(in
du
st
ry
-s
po
ns
or
ed
) 
D
es
cr
ip
tiv
e 
st
at
is
tic
s 
(p
er
ce
nt
ag
es
); 
te
m
po
ra
l c
ha
ng
es
 
w
er
e 
te
st
ed
 
N
o 
M
I p
at
ie
nt
s’
 ti
m
e 
to
 tr
ea
tm
en
t 
sh
or
te
ne
d 
an
d 
in
-h
os
pi
ta
l 
m
or
ta
lit
y 
di
m
in
is
he
d 
si
m
ul
ta
ne
ou
sl
y.
 
G
ua
la
no
 e
t a
l. 
(2
01
0)
:  
Te
m
po
ra
l t
re
nd
s 
in
 th
e 
us
e 
of
 d
ru
g-
el
ut
in
g 
st
en
ts
 fo
r 
ap
pr
ov
ed
 a
nd
 o
ff-
la
be
l 
in
di
ca
tio
ns
: a
 lo
ng
itu
di
na
l 
an
al
ys
is
 o
f a
 la
rg
e 
m
ul
tic
en
te
r p
er
cu
ta
ne
ou
s 
co
ro
na
ry
 in
te
rv
en
tio
n 
re
gi
st
ry
. 
In
va
si
ve
 
tre
at
m
en
t o
f 
co
ro
na
ry
 h
ea
rt 
di
se
as
e,
 
es
pe
ci
al
ly
 b
y 
ba
re
-m
et
al
 s
te
nt
 
(B
M
S
) a
nd
 d
ru
g-
el
ut
in
g 
st
en
t 
(D
E
S
) 
P
at
ie
nt
 g
ro
up
s 
(S
TE
M
I, 
P
C
I, 
ve
in
 
gr
af
t i
nt
er
ve
nt
io
n)
;  
ty
pe
 o
f s
te
nt
 o
r 
op
er
at
io
n;
 
su
bg
ro
up
 a
na
ly
si
s 
am
on
g 
pa
tie
nt
s 
w
ith
 d
ia
be
te
s 
  
U
S
A
 
20
06
–2
00
8 
R
eg
io
na
l r
eg
is
te
r, 
th
e 
B
lu
e 
C
ro
ss
 B
lu
e 
S
hi
el
d 
of
 M
ic
hi
ga
n 
C
ar
di
ov
as
cu
la
r 
C
on
so
rti
um
 
D
es
cr
ip
tiv
e 
st
at
is
tic
s 
(fr
eq
ue
nc
ie
s,
 
m
ea
ns
, m
ed
ia
ns
); 
ta
bu
la
te
d 
by
  s
ex
, 
ag
e,
 d
is
ea
se
 
hi
st
or
y,
 ty
pe
 o
f 
ad
m
is
si
on
, r
eg
io
n 
N
o 
Th
is
 o
bs
er
va
tio
na
l r
ea
l-w
or
ld
 
st
ud
y 
st
re
ng
th
en
ed
 th
e 
ev
id
en
ce
 
th
at
 p
at
ie
nt
s 
tre
at
ed
 w
ith
 d
ru
g-
el
ut
in
g 
st
en
t h
ad
 in
cr
ea
se
d 
ris
k 
of
 v
er
y 
la
te
 s
te
nt
 th
ro
m
bo
si
s 
(c
om
pa
re
d 
w
ith
 p
at
ie
nt
s 
tre
at
ed
 
w
ith
 b
ar
e-
m
et
al
 s
te
nt
s)
. 
Te
m
po
ra
l t
re
nd
 in
 d
ru
g-
el
ut
in
g 
st
en
t d
ec
re
as
in
g.
 
K
al
tia
la
-H
ei
no
 e
t a
l. 
(2
00
3)
:  
In
pa
tie
nt
 tr
ea
tm
en
t o
f 
m
oo
d 
di
so
rd
er
s 
in
 th
e 
er
a 
of
 d
e-
in
st
itu
tio
na
lis
at
io
n,
 
de
pr
es
si
on
 a
w
ar
en
es
s 
ca
m
pa
ig
ns
 a
nd
 
de
ve
lo
pm
en
t o
f n
ew
 
an
tid
ep
re
ss
an
ts
.  
In
pa
tie
nt
 
tre
at
m
en
t f
or
 
m
oo
d 
di
so
rd
er
s 
Y
ea
rly
 c
oh
or
ts
 
Fi
nl
an
d 
 
19
87
–1
99
5 
(fo
llo
w
ed
 
un
til
 1
99
7)
 
N
at
io
na
l H
os
pi
ta
l 
D
is
ch
ar
ge
 R
eg
is
te
r 
(A
dm
in
is
tra
tiv
e 
re
gi
st
er
)  
D
es
cr
ip
tiv
e 
st
at
is
tic
s 
(n
um
be
rs
; 
pr
op
or
tio
ns
); 
 
st
an
da
rd
is
ed
 
nu
m
be
rs
;  
 
co
m
pa
ris
on
 
be
tw
ee
n 
gr
ou
ps
 
w
er
e 
te
st
ed
  
N
o 
In
pa
tie
nt
 tr
ea
tm
en
t o
f s
ev
er
e 
m
oo
d 
di
so
rd
er
s 
in
cr
ea
se
d 
in
 a
ll 
ki
nd
s 
of
 h
ea
lth
 c
ar
e 
in
st
itu
tio
ns
, 
in
 s
pi
te
 o
f d
e-
in
st
itu
tio
na
lis
at
io
n 
po
lic
y.
  
??
?Ka
ta
lin
ic
 e
t a
l. 
(2
00
9)
:  
Tr
en
ds
 in
 h
or
m
on
e 
th
er
ap
y 
an
d 
br
ea
st
 c
an
ce
r 
in
ci
de
nc
e 
- r
es
ul
ts
 fr
om
 
th
e 
G
er
m
an
 N
et
w
or
k 
of
 
C
an
ce
r R
eg
is
tr
ie
s.
  
M
en
op
au
sa
l 
ho
rm
on
e 
th
er
ap
y 
H
or
m
on
e 
th
er
ap
y 
gr
ou
ps
; t
im
e 
tre
nd
s;
 a
ge
 
gr
ou
ps
; r
eg
io
ns
 
G
er
m
an
y 
19
97
–2
00
5 
P
op
ul
at
io
n 
ba
se
d 
su
rv
ey
 b
as
ed
 o
n 
ca
nc
er
 re
gi
st
er
 (b
re
as
t 
ca
nc
er
) a
nd
 h
ea
lth
 
in
su
ra
nc
e 
re
gi
st
er
 
(h
or
m
on
e 
pr
es
cr
ip
tio
n)
 
R
at
es
, t
es
te
d 
by
 
re
gr
es
si
on
 
an
al
ys
es
  
A
ge
 s
ta
nd
ar
di
se
d 
 
M
en
op
au
sa
l h
or
m
on
e 
th
er
ap
y 
in
cr
ea
se
s 
th
e 
ris
k 
of
 fe
m
al
e 
br
ea
st
 c
an
ce
r. 
R
es
ul
ts
 s
ho
w
 a
 
dr
op
 o
f h
or
m
on
e 
th
er
ap
y 
pr
es
cr
ip
tio
n.
 T
he
re
 w
er
e 
ge
og
ra
ph
ic
al
 d
iff
er
en
ce
s 
in
 th
e 
pr
es
cr
ip
tio
n 
of
 h
or
m
on
e 
th
er
ap
y.
  
K
ou
rt
is
 e
t a
l. 
(2
00
7)
:  
Tr
en
ds
 in
 h
os
pi
ta
liz
at
io
ns
 
of
 H
IV
-in
fe
ct
ed
 c
hi
ld
re
n 
an
d 
ad
ol
es
ce
nt
s 
in
 th
e 
U
ni
te
d 
St
at
es
: a
na
ly
si
s 
of
 
da
ta
 fr
om
 th
e 
19
94
-2
00
3 
N
at
io
nw
id
e 
In
pa
tie
nt
 
Sa
m
pl
e.
  
H
IV
-r
el
at
ed
 
ho
sp
ita
liz
at
io
ns
 
an
d 
th
e 
av
er
ag
e 
le
ng
th
 o
f 
ho
sp
ita
l s
ta
y 
B
oy
s 
an
d 
gi
rls
; 
ag
e;
 d
ia
gn
os
tic
 
gr
ou
ps
  (
w
ith
 a
nd
 
w
ith
ou
t H
IV
-
in
fe
ct
io
n)
  
U
S
A
 
19
94
–2
00
3 
Th
e 
N
at
io
nw
id
e 
In
pa
tie
nt
 S
am
pl
e 
da
ta
ba
se
 is
 a
n 
al
l-
pa
ye
r i
np
at
ie
nt
 c
ar
e 
da
ta
ba
se
 a
nd
 c
ov
er
s 
ca
 2
0%
 o
f a
ll 
U
S
 
co
m
m
un
ity
 h
os
pi
ta
ls
 
(n
on
fe
de
ra
l, 
sh
or
t-
te
rm
 g
en
er
al
 a
nd
 
sp
ec
ia
lty
 h
os
pi
ta
ls
 
w
ho
se
 fa
ci
lit
ie
s 
ar
e 
op
en
 to
 th
e 
pu
bl
ic
) 
D
es
cr
ip
tiv
e 
st
at
is
tic
s 
(n
um
be
rs
), 
di
ffe
re
nc
es
 te
st
ed
 
by
 re
gr
es
si
on
   
A
dj
us
te
d 
by
 a
ge
 a
nd
 
se
x 
A
fte
r i
nt
ro
du
ci
ng
 a
nt
ire
tro
vi
ra
l 
th
er
ap
y 
in
 1
99
7 
ho
sp
ita
liz
at
io
ns
 
am
on
g 
H
IV
-in
fe
ct
ed
 c
hi
ld
re
n 
de
cr
ea
se
d.
 C
om
pa
re
d 
to
 
ch
ild
re
n 
w
ith
ou
t H
IV
 c
hi
ld
re
n 
w
ith
 H
IV
 h
ad
 lo
ng
er
 m
ea
n 
ho
sp
ita
l s
ta
ys
.  
K
uk
lin
a 
et
 a
l. 
(2
01
1)
: 
Tr
en
ds
 in
 p
re
gn
an
cy
 
ho
sp
ita
liz
at
io
ns
 th
at
 
in
cl
ud
ed
 a
 s
tr
ok
e 
in
 th
e 
U
ni
te
d 
St
at
es
 fr
om
 1
99
4 
to
 
20
07
: r
ea
so
ns
 fo
r 
co
nc
er
n?
 
H
os
pi
ta
liz
at
io
ns
 
du
e 
to
 s
tro
ke
 fo
r 
w
om
en
 in
 th
e 
an
te
na
ta
l, 
de
liv
er
y,
 a
nd
 
po
st
pa
rtu
m
 
pe
rio
ds
 
Ti
m
in
g 
(a
nt
en
at
al
, 
de
liv
er
y,
 a
nd
  
po
st
pa
rtu
m
); 
 
by
 ty
pe
 o
f s
tro
ke
 
U
S
A
 
19
94
–2
00
7 
Th
e 
N
at
io
nw
id
e 
In
pa
tie
nt
 S
am
pl
e 
is
 a
 
st
ra
tif
ie
d 
sa
m
pl
e 
of
  
20
%
 o
f a
ll 
U
S
 
co
m
m
un
ity
 h
os
pi
ta
ls
 
of
 th
e 
H
ea
lth
ca
re
C
os
t 
an
d 
U
til
iz
at
io
n 
P
ro
je
ct
  
W
ei
gh
te
d 
pe
rc
en
t, 
on
 th
e 
ba
si
s 
of
 th
e 
sa
m
pl
e 
es
tim
at
ed
 
nu
m
be
rs
, 
pr
ev
al
en
ce
, r
at
es
, 
te
st
ed
 b
y 
re
gr
es
si
on
  
A
dj
us
te
d 
by
 a
ge
; 
ho
sp
ita
l r
eg
io
n;
 
in
su
ra
nc
e 
st
at
us
; 
co
m
or
bi
di
ty
 (h
ea
rt 
di
se
as
e,
 
hy
pe
rte
ns
iv
e 
di
so
rd
er
s,
 
po
st
pa
rtu
m
 
he
m
or
rh
an
ge
, 
po
st
pa
rtu
m
 
in
fe
ct
io
ns
)  
P
re
gn
an
cy
-r
el
at
ed
 
ho
sp
ita
liz
at
io
ns
 w
ith
 s
tro
ke
 
in
cr
ea
se
d,
 e
sp
ec
ia
lly
 d
ur
in
g 
th
e 
po
st
pa
rtu
m
 p
er
io
d.
 C
on
cu
rr
en
t 
hy
pe
rte
ns
iv
e 
di
so
rd
er
s 
an
d 
he
ar
t d
is
ea
se
s 
ex
pl
ai
ne
d 
al
m
os
t 
al
l o
f t
he
 in
cr
ea
se
 in
 p
os
tp
ar
tu
m
 
ho
sp
ita
liz
at
io
ns
 w
ith
 s
tro
ke
.  
 
La
y 
et
 a
l. 
(2
00
7)
:  
Tr
en
ds
 in
 p
sy
ch
ia
tr
ic
 
ho
sp
ita
lis
at
io
n 
of
 p
eo
pl
e 
w
ith
 s
ch
iz
op
hr
en
ia
: a
 
re
gi
st
er
-b
as
ed
 
in
ve
st
ig
at
io
n 
ov
er
 th
e 
la
st
 
th
re
e 
de
ca
de
s.
  
U
til
is
at
io
n 
of
 
in
pa
tie
nt
 
ps
yc
hi
at
ric
 
se
rv
ic
es
 
M
en
 a
nd
 w
om
en
;  
ag
e;
 ti
m
e 
tre
nd
s;
 
di
ag
no
st
ic
 g
ro
up
s 
S
w
itz
er
la
nd
  
19
77
–2
00
4 
A
 re
gi
on
al
 p
sy
ch
ia
tri
c 
re
gi
st
er
 d
at
a 
of
 th
e 
S
w
is
s 
ca
nt
on
 Z
ur
ic
h 
a 
ca
tc
hm
en
t a
re
a 
co
m
pr
is
in
g 
ab
ou
t 1
.2
 
m
ill
io
n 
in
ha
bi
ta
nt
s 
 
N
um
be
r o
f i
np
at
ie
nt
 
ad
m
is
si
on
s 
pe
r 
ye
ar
; t
he
 m
ed
ia
n 
le
ng
th
 o
f i
nd
iv
id
ua
l 
in
pa
tie
nt
 e
pi
so
de
s;
 
pa
tie
nt
-y
ea
rs
 in
 
tre
at
m
en
t; 
th
e 
tre
at
m
en
t 
pr
ev
al
en
ce
 b
y 
ye
ar
 
es
tim
at
ed
 b
y 
 
re
gr
es
si
on
 
A
dj
us
te
d 
by
 a
ge
, 
se
x,
  y
ea
r, 
di
ag
no
si
s 
 
A
t t
he
 ti
m
e 
of
 d
ow
ns
iz
in
g 
of
 
ps
yc
hi
at
ric
 h
os
pi
ta
ls
 m
en
ta
l 
he
al
th
 s
er
vi
ce
 u
se
 a
m
on
g 
sc
hi
zo
ph
re
ni
a 
pa
tie
nt
s 
de
cr
ea
se
d,
 a
nd
 le
ng
th
 o
f s
ta
y 
sh
or
te
ne
d 
si
m
ul
ta
ne
ou
sl
y.
 F
or
 
ot
he
r m
en
ta
l d
is
or
de
rs
 th
e 
tre
nd
 
of
 in
pa
tie
nt
 tr
ea
tm
en
t i
nc
re
as
ed
.  ??
?Ka
ta
lin
ic
 e
t a
l. 
(2
00
9)
:  
Tr
en
ds
 in
 h
or
m
on
e 
th
er
ap
y 
an
d 
br
ea
st
 c
an
ce
r 
in
ci
de
nc
e 
- r
es
ul
ts
 fr
om
 
th
e 
G
er
m
an
 N
et
w
or
k 
of
 
C
an
ce
r R
eg
is
tr
ie
s.
  
M
en
op
au
sa
l 
ho
rm
on
e 
th
er
ap
y 
H
or
m
on
e 
th
er
ap
y 
gr
ou
ps
; t
im
e 
tre
nd
s;
 a
ge
 
gr
ou
ps
; r
eg
io
ns
 
G
er
m
an
y 
19
97
–2
00
5 
P
op
ul
at
io
n 
ba
se
d 
su
rv
ey
 b
as
ed
 o
n 
ca
nc
er
 re
gi
st
er
 (b
re
as
t 
ca
nc
er
) a
nd
 h
ea
lth
 
in
su
ra
nc
e 
re
gi
st
er
 
(h
or
m
on
e 
pr
es
cr
ip
tio
n)
 
R
at
es
, t
es
te
d 
by
 
re
gr
es
si
on
 
an
al
ys
es
  
A
ge
 s
ta
nd
ar
di
se
d 
 
M
en
op
au
sa
l h
or
m
on
e 
th
er
ap
y 
in
cr
ea
se
s 
th
e 
ris
k 
of
 fe
m
al
e 
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tic
s 
(n
um
be
rs
, 
pe
rc
en
ta
ge
s)
; r
at
io
s 
us
in
g 
re
gr
es
si
on
   
A
cc
es
s 
tre
nd
s 
w
er
e 
ad
ju
st
ed
 b
y 
ag
e,
 
se
x,
 ra
ce
, B
M
I, 
sm
ok
in
g 
st
at
us
, 
re
fe
rr
al
 ty
pe
, 
pr
ov
in
ce
s 
of
 
re
si
de
nc
e,
 c
au
se
 o
f 
en
d-
st
ag
e 
re
na
l 
di
se
as
e,
 a
nd
 
co
m
or
bi
di
tie
s 
 
P
at
ie
nt
s 
in
iti
at
in
g 
he
m
od
ia
ly
si
s 
w
ith
 a
 c
at
he
te
r h
av
e 
an
 
in
cr
ea
se
d 
ris
k 
fo
r d
ea
th
 
co
m
pa
re
d 
w
ith
 th
os
e 
us
in
g 
fis
tu
la
 o
r g
ra
ft.
 In
ci
de
nt
 c
at
he
te
r 
us
e 
in
 h
em
od
ia
ly
si
s 
in
cr
ea
se
d,
 
fis
tu
la
 u
se
 d
ec
re
as
ed
, a
nd
 g
ra
ft 
us
e 
re
m
ai
ne
d 
st
ab
le
. 
P
re
va
le
nc
e 
of
 c
at
he
te
r u
se
 
in
cr
ea
se
d,
 a
nd
 fi
st
ul
as
 a
nd
 
gr
af
ts
 d
ec
re
as
ed
. D
iff
er
en
t 
ge
og
ra
ph
ic
al
 a
re
as
 v
ar
y 
in
 
in
ci
de
nc
e 
an
d 
pr
ev
al
en
ce
 in
 th
e 
us
e 
of
 c
at
he
te
rs
.  
 
Pe
te
rs
on
 e
t a
l. 
(2
00
8)
:  
Tr
en
ds
 in
 q
ua
lit
y 
of
 c
ar
e 
fo
r p
at
ie
nt
s 
w
ith
 a
cu
te
 
m
yo
ca
rd
ia
l i
nf
ar
ct
io
n 
in
 
th
e 
N
at
io
na
l R
eg
is
tr
y 
of
 
M
yo
ca
rd
ia
l I
nf
ar
ct
io
n 
fr
om
 
19
90
 to
 2
00
6.
  
E
vi
de
nc
e 
ba
se
d 
m
ed
ic
in
e 
an
d 
in
va
si
ve
 
tre
at
m
en
t f
or
 
ac
ut
e 
m
yo
ca
rd
ia
l 
in
fa
rc
tio
n 
 
W
om
en
 a
nd
 m
en
; 
bl
ac
k 
an
d 
w
hi
te
; 
ag
e 
gr
ou
ps
; 
di
ffe
re
nt
 y
ea
rs
  
U
S
A
  
19
90
–2
00
6 
N
at
io
na
l R
eg
is
try
 o
f 
M
yo
ca
rd
ia
l I
nf
ar
ct
io
n 
(N
R
M
I) 
a 
vo
lu
nt
ar
y 
pr
og
ra
m
 fo
r h
os
pi
ta
ls
  
D
es
cr
ip
tiv
e 
st
at
is
tic
s 
 
(n
um
be
rs
); 
w
ei
gh
te
d 
pe
rc
en
ta
ge
s;
 ra
tio
s 
us
in
g 
 re
gr
es
si
on
; 
tim
e 
tre
nd
 w
er
e 
te
st
ed
  
A
dj
us
te
d 
fo
r a
ge
, 
se
x,
 ra
ce
, p
ay
er
, 
ho
sp
ita
l 
ch
ar
ac
te
ris
tic
s,
 
m
ed
ic
al
 h
is
to
ry
 
(a
ng
in
a,
 c
or
on
ar
y 
ar
te
ry
 b
yp
as
s 
gr
af
t 
su
rg
er
y,
 fa
m
ily
 
hi
st
or
y 
of
 c
or
on
ar
y 
ar
te
ry
 d
is
ea
se
, h
ea
rt 
fa
ilu
re
, d
ia
be
te
s,
 
hy
pe
rli
pi
de
m
ia
, 
hy
pe
rte
ns
io
n,
 
pr
ev
io
us
 A
M
I, 
P
C
I, 
sm
ok
er
, s
tro
ke
), 
cl
in
ic
al
 p
re
se
nt
at
io
n,
 
an
d 
tra
ns
fe
r-
in
 
st
at
us
 
Th
e 
us
e 
of
 re
co
m
m
en
de
d 
th
er
ap
ie
s 
(m
ed
ic
at
io
n,
 in
va
si
ve
 
pr
oc
ed
ur
es
) i
nc
re
as
ed
 in
 th
e 
tre
at
m
en
t o
f A
M
I. 
C
ar
di
ac
 
ca
th
et
er
iz
at
io
n 
an
d 
pe
rc
ut
an
eo
us
 c
or
on
ar
y 
in
te
rv
en
tio
n 
us
e 
in
cr
ea
se
d,
  
w
he
re
as
 c
or
on
ar
y 
by
pa
ss
 
su
rg
er
y 
us
e 
di
m
in
is
he
d.
 
W
om
en
, b
la
ck
s,
 a
nd
 p
at
ie
nt
s 
≥7
5 
ye
ar
s 
ol
d 
w
er
e 
le
ss
 li
ke
ly
 to
 
re
ce
iv
e 
re
va
sc
ul
ar
is
at
io
n 
or
 
be
in
g 
di
sc
ha
rg
ed
 w
ith
 li
pi
d-
lo
w
er
in
g 
th
er
ap
y 
th
ro
ug
ho
ut
 th
e 
st
ud
y 
pe
rio
d.
 
? ? A
ut
ho
r(
s)
, p
ub
lic
at
io
n 
ye
ar
, a
nd
 ti
tle
 
M
ed
ic
al
 
pr
ac
tic
e 
G
ro
up
s 
co
m
pa
re
d 
C
ou
nt
ry
 a
nd
 
tim
e 
pe
rio
d 
 
Ty
pe
 o
f r
eg
is
te
r  
M
et
ho
d 
of
 
an
al
ys
is
 
C
as
e 
m
ix
 
co
rr
ec
tio
n 
 
R
es
ul
ts
   
Pi
jl 
an
d 
Sy
te
m
a 
(2
00
3)
:  
Th
e 
id
en
tif
ic
at
io
n 
of
 
tr
en
ds
 in
 th
e 
ut
ili
sa
tio
n 
of
 
m
en
ta
l h
ea
lth
 s
er
vi
ce
s 
by
 
el
de
rly
: a
 D
ut
ch
 c
as
e 
re
gi
st
er
 s
tu
dy
.  
U
se
 o
f 
co
m
m
un
ity
- a
nd
 
ho
sp
ita
l-b
as
ed
 
se
rv
ic
es
 (2
4-
ho
ur
 c
ar
e)
 d
ue
 
to
 m
en
ta
l h
ea
lth
 
pr
ob
le
m
s 
Ty
pe
 o
f s
er
vi
ce
 
(c
om
m
un
ity
- v
s.
  
ho
sp
ita
l-b
as
ed
 
se
rv
ic
es
); 
ag
e 
gr
ou
ps
; d
iff
er
en
t 
ye
ar
s 
Th
e 
 
N
et
he
rla
nd
s 
19
90
–1
99
9 
A
 lo
ca
l p
sy
ch
ia
tri
c 
ca
se
 re
gi
st
er
 
D
es
cr
ip
tiv
e 
st
at
is
tic
s 
(n
um
be
rs
, 
in
ci
de
nc
e 
an
d 
pr
ev
al
en
ce
 p
er
 
10
00
 p
op
ul
at
io
n)
; 
de
ca
de
 c
ha
ng
es
 
(%
); 
 
un
it 
co
st
s 
of
 m
en
ta
l 
he
al
th
 s
er
vi
ce
s 
 
N
o/
 ta
bu
la
te
d 
by
 a
ge
 
gr
ou
ps
 
A
t t
he
 ti
m
e 
of
 
de
in
st
itu
tio
na
lis
at
io
n 
do
m
in
an
t i
n 
m
en
ta
l h
ea
lth
 p
ol
ic
y,
 m
en
ta
l 
he
al
th
 s
er
vi
ce
 u
se
 d
ec
re
as
ed
, 
bu
t t
he
 le
ng
th
 o
f s
ta
y 
in
cr
ea
se
d.
  
Pr
ift
is
 e
t a
l. 
(2
00
7)
:  
D
ec
re
as
e 
in
 c
hi
ld
ho
od
 
as
th
m
a 
ad
m
is
si
on
s 
in
 
A
th
en
s,
 G
re
ec
e 
fr
om
 2
00
1 
to
 2
00
5.
  
A
st
hm
a 
ad
m
is
si
on
s 
D
iff
er
en
t y
ea
rs
; 
ag
e 
gr
ou
ps
 
G
re
ec
e 
19
78
–2
00
6 
H
os
pi
ta
l r
eg
is
te
rs
 o
f 
th
e 
th
re
e 
m
ai
n 
C
hi
ld
re
n'
s 
ho
sp
ita
ls
 o
f 
A
th
en
s,
 c
ov
er
in
g 
ar
ou
nd
 8
5%
 o
f 
pa
ed
ia
tri
c 
be
ds
 in
 th
e 
re
gi
on
 
E
st
im
at
ed
 
ad
m
is
si
on
s 
pe
r 
10
00
00
; 
re
ad
m
is
si
on
s/
 
ad
m
is
si
on
s 
ra
te
s 
(%
); 
tim
e 
tre
nd
s 
w
er
e 
as
se
ss
ed
 b
y 
re
gr
es
si
on
 a
nd
 
te
st
ed
 fo
r t
re
nd
  
N
o/
 d
iv
id
ed
 b
y 
ag
e 
gr
ou
p 
C
hi
ld
ho
od
 a
st
hm
a 
ad
m
is
si
on
s 
de
cr
ea
se
d.
 
R
an
ta
la
ih
o 
et
 a
l. 
(2
01
1)
:  
Tr
en
ds
 in
 tr
ea
tm
en
t 
st
ra
te
gi
es
 a
nd
 th
e 
us
ag
e 
of
 d
iff
er
en
t d
is
ea
se
-
m
od
ify
in
g 
an
ti-
rh
eu
m
at
ic
 
dr
ug
s 
in
 e
ar
ly
 rh
eu
m
at
oi
d 
ar
th
rit
is
 in
 F
in
la
nd
. 
R
es
ul
ts
 fr
om
 a
 n
at
io
nw
id
e 
re
gi
st
er
 in
 2
00
0–
20
07
.  
Tr
ea
tm
en
t o
f 
ea
rly
 rh
eu
m
at
oi
d 
ar
th
rit
is
 u
si
ng
 
di
se
as
e-
m
od
ify
in
g 
 a
nt
i-
rh
eu
m
at
ic
 d
ru
gs
  
A
nn
ua
l c
oh
or
ts
; 
va
rio
us
 a
nt
i-
rh
eu
m
at
ic
 d
ru
g 
Fi
nl
an
d 
20
00
–2
00
7 
N
at
io
na
l r
eg
is
te
r o
f 
m
ed
ic
in
e 
re
-
im
bu
rs
em
en
ts
 
(a
dm
in
is
tra
tiv
e,
 
ob
lig
at
or
y 
 re
gi
st
er
s)
   
D
es
cr
ip
tiv
e 
st
at
is
tic
s 
(n
um
be
rs
, 
pe
rc
en
ta
ge
s)
; 
co
m
pa
ris
on
s 
be
tw
ee
n 
gr
ou
ps
 
w
er
e 
an
al
ys
ed
 b
y 
an
al
ys
is
 o
f v
ar
ia
nc
e 
 
N
o 
 
Th
er
e 
w
as
 a
 c
ha
ng
e 
in
 
tre
at
m
en
t s
tra
te
gy
 in
 th
e 
us
e 
of
 
di
se
as
e-
m
od
ify
in
g 
an
ti-
rh
eu
m
at
ic
 d
ru
gs
, a
nd
 m
ed
ic
in
e 
us
e 
in
cr
ea
se
d 
ov
er
al
l. 
R
av
er
a 
et
 a
l. 
(2
01
0)
: 
Pr
ev
al
en
ce
, c
um
ul
at
iv
e 
in
ci
de
nc
e,
 m
on
ot
he
ra
py
 
an
d 
co
m
bi
na
tio
n 
th
er
ap
y,
 
an
d 
tr
ea
tm
en
t d
ur
at
io
n 
of
 
fr
eq
ue
nt
ly
 p
re
sc
rib
ed
 
ps
yc
ho
ac
tiv
e 
m
ed
ic
at
io
ns
 
in
 th
e 
N
et
he
rla
nd
s:
 
re
tr
os
pe
ct
iv
e 
da
ta
ba
se
 
an
al
ys
is
 fo
r t
he
 y
ea
rs
 2
00
0 
to
 2
00
5.
  
P
sy
ch
oa
ct
iv
e 
dr
ug
 
pr
es
cr
ip
tio
ns
 
m
en
 a
nd
 w
om
en
; 
di
ffe
re
nt
 y
ea
rs
; 
ag
e 
gr
ou
ps
;  
Th
e 
 
N
et
he
rla
nd
s 
20
00
–2
00
5 
A
 re
gi
on
al
 d
at
ab
as
e 
in
cl
ud
in
g 
in
fo
rm
at
io
n 
w
ith
 p
ha
rm
ac
y 
di
sp
en
si
ng
 d
at
a 
fro
m
 
a 
po
pu
la
tio
n 
of
 
�5
00
,0
00
 p
eo
pl
e 
in
 
th
e 
no
rth
er
n 
re
gi
on
 o
f 
th
e 
N
et
he
rla
nd
s 
P
re
va
le
nc
e 
pe
r 
10
00
; c
um
ul
at
iv
e 
in
ci
de
nc
e 
w
ith
 C
I 
95
%
; s
ur
vi
va
l 
cu
rv
es
 fo
r d
ur
at
io
n 
of
 p
re
sc
rip
tio
ns
 
N
o/
 d
iv
id
ed
 b
y 
ag
e 
gr
ou
p 
P
sy
ch
oa
ct
iv
e 
dr
ug
 u
se
 w
as
 
re
la
tiv
el
y 
st
ab
le
, a
lth
ou
gh
 th
er
e 
w
er
e 
so
m
e 
ch
an
ge
s 
in
 s
pe
ci
fic
 
dr
ug
 c
at
eg
or
ie
s 
(e
.g
., 
sl
ig
ht
 
in
cr
ea
se
 in
 th
e 
pr
ev
al
en
ce
 o
f 
an
tip
sy
ch
ot
ic
s 
an
d 
an
tid
ep
re
ss
an
ts
 a
nd
 s
lig
ht
 
de
cr
ea
se
 o
f a
nx
io
ly
tic
s)
. T
he
 
m
ed
ia
n 
tre
at
m
en
t d
ur
at
io
n 
w
as
 
lo
ng
es
t w
ith
 a
nt
ip
sy
ch
ot
ic
s 
an
d 
sh
or
te
st
 w
ith
 a
nx
io
ly
tic
s.
  
M
un
k-
Jo
rg
en
se
n 
et
 a
l. 
(1
99
2)
:  
Tr
en
ds
 in
 p
sy
ch
ia
tr
ic
 
ho
sp
ita
liz
at
io
n 
in
 
D
en
m
ar
k:
 a
 1
0-
ye
ar
 
re
gi
st
er
-b
as
ed
 
in
ve
st
ig
at
io
n.
  
A
dm
is
si
on
s 
to
 
ps
yc
hi
at
ric
 
ho
sp
ita
ls
 a
nd
 
de
pa
rtm
en
ts
  
M
en
 a
nd
 w
om
en
; 
ye
ar
; m
ai
n 
di
ag
no
si
s 
gr
ou
ps
 
(s
ch
iz
op
hr
en
ia
, 
m
an
ic
 d
ep
re
ss
iv
e 
ps
yc
ho
se
s,
 
or
ga
ni
c 
di
so
rd
er
s,
 
re
ac
tiv
e 
co
nd
iti
on
s,
  o
th
er
 
di
ag
no
se
s)
; a
ge
; 
nu
m
be
r o
f 
po
pu
la
tio
n 
of
 th
e 
ar
ea
 
D
en
m
ar
k 
19
77
–1
98
7 
N
at
io
na
l C
en
tra
l 
ps
yc
hi
at
ric
 re
gi
st
er
 
in
cl
ud
es
 in
fo
rm
at
io
n 
on
 a
dm
is
si
on
s 
to
 
ps
yc
hi
at
ric
 h
os
pi
ta
ls
 
di
re
ct
 a
ge
 
st
an
da
rd
is
ed
 ra
te
s;
 
tre
nd
 w
as
 a
na
ly
se
d 
by
 re
gr
es
si
on
  
A
dj
us
te
d 
by
 a
ge
  
A
t t
he
 ti
m
e 
of
 d
ec
re
as
in
g 
ps
yc
hi
at
ric
 b
ed
s 
in
 h
os
pi
ta
ls
,  
ad
m
is
si
on
 ra
te
s 
fo
r m
os
t 
ps
yc
hi
at
ric
 d
ia
gn
os
is
 g
ro
up
s 
de
cr
ea
se
d,
 a
nd
 th
e 
de
cr
ea
se
 
w
as
 m
os
t p
ro
no
un
ce
d 
in
 th
e 
el
de
rly
. H
ow
ev
er
 in
 
sc
hi
zo
ph
re
ni
a 
a 
tre
nd
 o
f 
in
cr
ea
si
ng
 a
dm
is
si
on
 ra
te
s 
w
as
 
fo
un
d.
  
N
gu
ye
n 
et
 a
l. 
(2
01
0)
:  
A
ge
 a
nd
 s
ex
 d
iff
er
en
ce
s,
 
an
d 
ch
an
gi
ng
 tr
en
ds
, i
n 
th
e 
us
e 
of
 e
vi
de
nc
e-
ba
se
d 
th
er
ap
ie
s 
in
 a
cu
te
 
co
ro
na
ry
 s
yn
dr
om
es
: 
pe
rs
pe
ct
iv
es
 fr
om
 a
 
m
ul
tin
at
io
na
l r
eg
is
tr
y.
 
C
ar
di
ac
 
m
ed
ic
at
io
n 
an
d 
pr
oc
ed
ur
e 
us
e 
M
en
 a
nd
 w
om
en
; 
ag
e 
gr
ou
ps
  
N
or
th
 a
nd
 
S
ou
th
 
A
m
er
ic
a,
 
E
ur
op
e,
 
A
us
tra
lia
 a
nd
 
N
ew
 Z
ea
la
nd
 
19
99
–2
00
7 
Th
e 
G
lo
ba
l R
eg
is
try
 o
f 
A
cu
te
 C
or
on
ar
y 
E
ve
nt
s 
(G
R
A
C
E
) 
st
ud
y 
 
D
es
cr
ip
tiv
e 
st
at
is
tic
s 
(n
um
be
rs
, 
pe
rc
en
ta
ge
s,
  
m
ed
ia
ns
); 
ra
te
s;
 
di
ffe
re
nc
es
 
be
tw
ee
n 
gr
ou
ps
 
te
st
ed
; r
eg
re
ss
io
n 
m
od
el
s 
 
A
dj
us
te
d 
fo
r a
ge
, 
se
x,
 s
tu
dy
 p
er
io
d,
 
ad
di
tio
na
lly
 s
om
e 
m
od
el
s 
us
ed
 
ho
sp
ita
l t
yp
e,
 c
o-
m
or
bi
di
tie
s,
 a
nd
 
cl
in
ic
al
 
ch
ar
ac
te
ris
tic
s 
In
cr
ea
si
ng
 tr
en
d 
in
 e
vi
de
nc
e 
ba
se
d 
m
ed
ic
in
e 
an
d 
ca
rd
ia
c 
pr
oc
ed
ur
es
 w
as
 re
po
rte
d 
ov
er
 
tim
e.
 U
til
is
at
io
n 
w
as
 p
er
si
st
en
tly
 
lo
w
er
 a
m
on
g 
el
de
rly
 p
at
ie
nt
s 
an
d 
yo
un
ge
r w
om
en
. 
R
ob
er
ts
so
n 
et
 a
l. 
(2
00
0)
:  
Pa
st
 in
ci
de
nc
e 
an
d 
fu
tu
re
 
de
m
an
d 
fo
r k
ne
e 
ar
th
ro
pl
as
ty
 in
 S
w
ed
en
: a
 
re
po
rt
 fr
om
 th
e 
Sw
ed
is
h 
K
ne
e 
A
rt
hr
op
la
st
y 
R
eg
is
te
r r
eg
ar
di
ng
 th
e 
ef
fe
ct
 o
f p
as
t a
nd
 fu
tu
re
 
po
pu
la
tio
n 
ch
an
ge
s 
on
 th
e 
nu
m
be
r o
f a
rt
hr
op
la
st
ie
s 
pe
rf
or
m
ed
.  
P
rim
ar
y 
kn
ee
 
ar
th
ro
pl
as
tie
s 
 
M
en
 a
nd
 w
om
en
; 
tim
e;
 a
ge
; 
di
se
as
es
  
(o
st
eo
ar
th
rit
is
, 
rh
eu
m
at
oi
d 
ar
th
rit
is
; 
po
st
tra
um
at
ic
, 
os
te
on
ec
ro
si
s)
   
 
S
w
ed
en
 
19
76
–1
99
7 
N
at
io
na
l r
eg
is
te
r o
f 
kn
ee
 a
rth
ro
pl
as
ty
 (t
he
 
S
w
ed
is
h 
K
ne
e 
A
rth
ro
pl
as
ty
 R
eg
is
te
r)
 
an
d 
ce
ns
us
  
D
es
cr
ip
tiv
e 
st
at
is
tic
s 
(n
um
be
rs
; 
pe
rc
en
ta
ge
s)
 m
ea
n 
of
 y
ea
rly
 in
ci
de
nc
e 
in
 th
e 
tim
e 
pe
rio
d/
 
10
00
00
 in
ha
bi
ta
nt
s;
 
pr
oj
ec
te
d 
nu
m
be
rs
 
of
 n
ee
d 
of
 k
ne
e 
ar
th
ro
pl
as
tie
s 
in
 th
e 
fu
tu
re
 
N
o/
 ta
bu
la
te
d 
by
 
ag
e,
 s
ex
  
D
ur
in
g 
th
e 
st
ud
y 
pe
rio
d 
os
te
oa
rth
rit
is
 a
cc
ou
nt
ed
 fo
r t
he
 
la
rg
es
t i
nc
re
as
e 
in
 k
ne
e 
ar
th
ro
pl
as
tie
s,
 o
pe
ra
tio
ns
 fo
r 
rh
eu
m
at
oi
d 
ar
th
rit
is
 re
m
ai
ne
d 
st
ab
le
. O
ld
es
t a
ge
 g
ro
up
s 
ha
d 
th
e 
la
rg
es
t i
nc
re
as
e 
in
 
op
er
at
io
ns
. 
? ? A
ut
ho
r(
s)
, p
ub
lic
at
io
n 
ye
ar
, a
nd
 ti
tle
 
M
ed
ic
al
 
pr
ac
tic
e 
G
ro
up
s 
co
m
pa
re
d 
C
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Appendix 3  
Figure 8. Flow diagram of formulation of data in sub-study (I) 
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Figure 9. Flow diagram of formulation of data in sub-study (II) 
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Figure 10. Flow diagram of formulation of data in sub-study (III) 
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Figure 11. Flow diagram of formulation of data in sub-study (IV) 
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